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GENERAL SUMMARY
The aim of this thesis is to investigate some of the 
factors which affect the growth of metastasising cells at 
distant sites. Previous experiments, mostly involving 
intravenous injection of cultured murine B16 melanoma and 
other tumour cell lines, have suggested that sub­
populations of cells exist within tumours which are capable 
of metastasis, sometimes to specific organs. One criticism 
of these studies is that growth at a distant site is but 
one characteristic required for a cell to successfully form 
a metastatic deposit. The cell must also express other 
phenotypic characteristics such as motility and invasion 
and in some cases evasion of host defences.
Much of the experimental work in this thesis makes use 
of the Bl6 melanoma FIO and Fl cell lines. The FIG cell 
line was derived many years ago by repeated in vivo passage 
through the lungs of syngeneic mice while the Fl cell 
line was passaged in vivo only once and has been maintained 
exclusively in vitro. In this study it was found that the 
FIO cell line formed tumours at a high rate, exclusively in 
the lungs, whereas the Fl cell line was much less 
metastatic and selective in its site of growth. The use of 
radio-labelled cells showed that the FIO cells were more 
avidly trapped in the lungs than the Fl cells but the 
difference in lung trapping between the two cell lines was 
less marked than the difference in lung tumour formation. 
These results broadly confirm the results of earlier 
studies and show that despite prolonged culture the cell 
lines have been stable with respect to these properties.
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In contrast to the results of intravenous injection, 
when Fl and FIO cells were injected into the peritoneal 
cavity it was found that there was no difference in the 
number of tumours produced. Each cell line was then 
subjected to repeated intraperitoneal passage to see 
whether passaged cells formed more local tumours when 
injected peritoneally, whether such cells would home to the 
peritoneal cavity following intravenous injection, and if 
passage in the peritoneum would effect lung homing 
properties particularly of the FIO cell line. After 16 
passages an FIO cell line was produced which grew more 
readily in the peritoneal cavity but did not produce 
abdominal tumours when injected intravenously; lung tumour 
formation was unaffected. When Fl cells were passaged it 
was found that after 8 passages cell growth in vitro and in 
the peritoneal cavity was so greatly reduced that in only 
one of three sets of experiments was it possible to proceed 
beyond the eighth passage. The set of Fl cells which 
reached passage 16 continued to show poor growth in vitro 
and after intraperitoneal injection but surprisingly 
produced a much larger number of lung tumours following 
intravenous injection than the parent cell line. This 
latter change was not accompanied by increased cell 
trapping in the lungs.
By way of comparison a benign virus-induced salivary 
tumour was studied. This model was limited by failure to 
culture the tumour cells in vitro. When a cell suspension 
derived from this tumour was injected intraperitoneally no 
tumours resulted. Thus the benign nature of this tumour may 
have been partly due to an inability to grow at a distant 
site.
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An attempt was made to correlate adhesion of B16 and 
salivary tumour cells to tissue sections with their sites 
of growth but in contrast to previous studies no such 
correlation was found.
Mechanisms to account for these results are discussed 
with particular reference to the effects of selection, 
trapping by the vasculature and the influence exerted by 
local tissue environments on tumour cells. While these 
mechanisms are often difficult to separate experimentally 
there was some evidence that local environments may play a 
larger part than hitherto realised in controlling the 
growth of metastasising tumour cells.
Little is known of the molecular basis of tumour cell 
metastasis, though attempts to identify cell surface 
proteins and more recently the genes involved in the 
process have met with some success. Since the histo­
compatability proteins are known to participate in a wide 
range of cellular interactions, they may be involved in the 
process of metastatic tumour growth. Accordingly, 
monoclonal antibodies to the major histocompatability 
complex (MHC) K and D proteins and the class II I-A protein 
were used to study expression of these molecules in the B16 
Fl and FIO cells. Using a fluorescence activated cell 
sorter it was found that expression of these antigens was 
greater in the FIO than in the Fl cell. Treatment of the 
cells with retinoic acid caused increased expression of 
both class I and class II molecules, the increase being 
greater in the Fl cells. However attempts to study the 
changes in metastatic potential after retinoic acid 
induction were thwarted because of unexpected effects
1%
oi^  cell division. Retinoic acid produced a marked Increase 
in the lung trapping of F1 cells, at concentration which 
stimulated MHC expression. However, the opposite was true 
of FIO cells where a decrease in lung trapping was found 
after retinoic acid treatment. These results are discussed 
in the context of the various MHC effects which are 
described in other tumour models.
The role of histocompatability proteins was further 
studied by testing for strain related restriction effects 
such as those demonstrable in the immune system.
Intravenous injection of FIO cells into a semi-allogeneic 
recipient produced a large decrease in the number of lung 
lesions but not in the number of peritoneal deposits 
following intraperitoneal injection or in trapping of 
radio-labelled cells. Using a hybrid which was homozygous 
at H-2 but not at any other locus it was found that the 
decrease was not due to the H-2 locus but to other 
strain-related polymorphisms. On review of the literature 
it was apparent that this effect has been observed 
elsewhere but has not been previously commented on.
In view of their great diversity it is possible that 
the non-H-2 class I genes especially could be -important 
mediators of the cell interactions which govern the growth 
and positioning of metastasis. Unfortunately further 
investigation is inhibited by lack of suitable reagents and 
strains of animals of appropriate genotype.
CHAPTER ONE
GENERAL INTRODUCTION.
CHAPTER 1 
GENERAL INTRODUCTION
The work described in this thesis concerns the factors 
which control the growth of metastasising tumour cells at 
distant sites. There are two distinctive and complementary 
approaches to this problem. The first entails the search 
for sub-populations of cells within malignant tumours which 
are able to grow at distant sites. This is one aspect of 
the general question of tumour progression. The second 
approach concerns the phenotype of metastasising cells.
Many cellular characteristics correlate with the ability of 
tumour cells to form metastasis at distant sites. Some of 
these are of a general nature, for example, adhesion and 
motility, while others such as interaction with platelets 
relate to identifiable steps in the process of metastasis. 
In this chapter both these approaches to the problem will 
be considered in order to place the experimental work 
described in chapters 2 and 3 in a wider context.
1.1. Clinical Studies of Metastasis
The origin of the study of metastasis lies in human 
pathology and with a number of important observations. It 
has long been recognised that many malignant tumours 
metastasise to particular sites (Willis, 1952). It is 
clear that two factors govern the observed pattern. 
Metastasis to local lymph nodes or to the liver,in the case 
of gastrointestinal tumours is explicable on the basis of 
lymphatic or blood flow (Sugarbaker, 1981, Sugarbaker,
1979). However, the site preference of many tumours is not 
explained by this mechanism. An example is seen in figure 1 
of a malignant melanoma which colonised the duodenum but
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did not spread beyond the gastro-duodenal junction. The 
tendency for malignant lymphomas to colonise symmetrical 
structures such as the earlobes, conjunctiva or breasts has 
also been described (Morgan 1971). These observations lead 
to the hypothesis that site specific factors are present 
which favour or retard the growth of potentially metastatic 
cells. Further support for this hypothesis is found in the 
observed variation in growth rates of tumour cells at 
different sites. Metastatic breast carcinoma cells may 
become apparent many years after the removal of a primary 
tumour (Adair et al, 1974, American Joint Committee for 
Cancer Staging, 1978, Brinkley and Haybittle, 1975, Pawlias 
et al, 1958) which suggests the possibility that local 
factors may inhibit growth of these cells. There is also 
some evidence that the growth may be accelerated by local 
trauma and subsequent healing (Per Hagopian et al, 1978).
A second question raised by clinical studies is the 
nature of the relationship between cells which form 
métastasés and the general population of cells in the 
primary tumour. In some cases it has been found that the 
probability of finding metastasis is closely related to the 
size of a primary tumour (McNeal et al, 1986). This is not 
an invariable rule; many tumours may be undetectable at the 
primary site, but, present with multiple metastasis. For 
example, in tumours of the head and neck, size is 
predictive of the formation of metastasis by carcinoma of 
the mouth but not by carcinoma of the pharynx (Lindberg, 
1972). This suggests that the tumour phenotype which 
favours the formation of métastasés may differ from that 
which favours local growth and hence leads to a hypothesis
that metastasising sub-populations of cells may be present 
in a primary tumour. This idea is supported by many 
observations of differences in karyotype (Vindelov et al, 
1980, Shapiro et al,,1981, Abeloff et al, 1979 ), receptors 
(Brennan et al, 1979) and surface antigens (Dexter and 
Calabresi, 1982) between tumours and their métastasés.
1.2. Experimental Studies of Metastasis.
The clinical observations described above form the 
basis of the experimental study of metastasis. The studies 
which will be described seek answers to the following 
questions. Are distinct metastasising cell sub-populations 
present within a primary tumour ? Are sub-populations 
present which show a preference for growth at a particular 
distant site ? What properties must a tumour cell have to 
allow it to form a metastasis, either in general or at a 
particular site ?
a ) The Evolution of Metastasising Cells from a Primary 
Tumour.
The multistage model of carcinogenesis has become 
widely accepted. Three stages are recognised: initiation, 
promotion and progression (Farber & Cameron, 1980, Medline 
& Farber, 1981). The initiation and promotion steps can be 
readily demonstrated in mouse skin where the efficiency of 
the carcinogen is greatly enhanced by subsequent 
application of croton oil (Berenblum, 1941). These effects 
are also seen in mouse liver where partial hepatectomy 
increases the yield of hepatomas following a single dose of 
a chemical carcinogen (Soit et al, 1977). In cattle it has 
been postulated that food constituents may promote the 
effects of papilloma virus infection in causing gastric 
carcinoma (Jarrett et al, 1978). It is reasonable to
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regard the initiation event as a stage of genetic injury. 
Many initiating agents may give rise to electrophilic 
agents capable of reacting with nucleic acids (Yahagi et 
al, 1975, DeBaun et al, 1970). In one case the genetic 
change following carcinogenesis has been shown to be a 
mutation of the ras proto-oncogene (Marshall et al, 1984). 
Promotion can be seen as a growth stimulus which may act by 
"fixing” the genetic change caused by the initiator or 
simply by stimulating cell division. The phorbol esters 
are important tumour promoters and probably act through 
the protein kinase C pathway in competition with endogenous 
diacylglycerol (Moolenaar et al, 1984).
The formation of metastasis is regarded as belonging 
to the third stage in carcinogenesis. In contrast to 
intitiation and promotion, progression is much more 
difficult to define in cellular or molecular terms. It is 
uncertain whether the genetic changes of the initiation 
step are sufficient or whether further change must occur, 
with the evolution of sub-populations before progression to 
metastasis. Many of the basic concepts of tumour 
progression were described by Nowell (Nowell, 1976). The 
model envisaged is one of evolution by natural selection; 
multiple variants being generated by mutation, most of 
which are eliminated, while a few persist and replace the 
progenitor cell population. Fundamental to this view is 
the idea that tumours have an acquired but inherited degree
of genetic instability. There is some evidence for this 
view in the increase in mitotic errors seen in neoplastic 
cells (Hellstrom et al, 1963) and the correlation of 
karyotypic abnormalities with increased malignancy
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(Rowley, 1975). Although some of the mechanisms of DMA 
repair are well understood (Lindahl, 1982) little is known 
about the overall control of genomic stability and how this 
mechanism could be impaired in neoplastic cells. An 
alternative view of tumour progression is that local 
environmental influences may modulate tumour cell behaviour 
without the need for further genetic change. There is 
little direct evidence for epigenetic factors of this type 
in tumour progression although in some cases the neoplastic 
behaviour of cells may be controlled by the environment 
even in the presence of gross karyotypic abnormalities.
The regulatory effects of embryonic tissue on 
teratocarcinoma cells is a good example (Pierce, 1983). In 
a recent review Hart, (1984) proposed six general 
principles of tumour progression. These are (1) individual 
characteristics progress independently (2) tumours evolve 
at different rates (3) progression is independent of tumour 
growth (4) progression may be continuous or discontinuous 
(5) progression follows one of the alternative paths of 
development (6) progression does not always reach an end 
point within the lifetime of the host. It is difficult to 
300 what these principles add to the understanding of the 
problem of tumour progression. Principles 1 — 4 appear to 
be simple restatements of the idea that progression is a 
function of genetic change. In principle 5 the author does 
not explain what he means by alternative pathways of 
development. The sixth principle merely alludes to the fact 
that in vitro cell lines may continue to change over very
long periods of time.
From the point of view of the study of metastasis the
L%
question of tumour progression is largely encompassed by 
the question as to whether or not métastasés arise from 
distinctive cell sub—populations within the primary 
tumour. If such sub—populations are demonstrated then it 
becomes relevant to ask how they were initially generated.
These questions will be approached in the following 
way. (1) The B16 mouse melanoma model will be described. 
Work with this model and its interpretation constitutes a 
very large proportion of the literature on this subject.
(2) Other models of metastasis in mice will be discussed.
(3) The arguments for and against the concept of 
heterogeneity and will be presented. (4) Possible 
mechanisms of generation of heterogeneity will be 
described.
b ) The B16 mouse melanoma
The B16 melanoma is a spontaneous tumour which arose 
in 1954 inaC57 BL6 mouse. It was initially passaged in 
vivo before it was permanently established in culture. The 
widespread use of this model in studying the process of 
metastasis stems from a much quoted experiment (Fidler & 
Kripke, 1977, Poste & Fidler, 1980). In this experiment 17 
individual clones were isolated from a sample of B16 
cells. Cells from each clone were injected intravenously 
into groups of syngeneic mice and the number of tumour 
deposits compared with those produced by the uncloned 
parent cell line. This experiment showed that most of the 
clones differed in their ability to produce tumours as 
compared to the parent cells. Sub-clones derived from some 
of the original clones were identical in tumour forming 
ability. From these experiments it was concluded that the
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parent cell line contained a heterogeneous population of 
cells differing in metastatic potential which was stably 
inherited.
Injection of cells from the parent cell line produced 
pulmonary lesions in every animal tested. Lesions were also 
apparent in the ovary, liver, gut, lymph nodes, adrenal 
glands, heart, kidney and nasal sinuses (Fidler and Kripke,
1977). Earlier work with B16 cells had produced cell lines 
selectively metastatic to particular organs. A lung 
selective line was produced (Fidler, 1973) by the in vivo 
culture of cells derived from pulmonary lesions followed by 
intravenous injection into the syngeneic host. Ten cycles 
of this type were required to produce a highly selective 
line designated B16 FIO. Cells derived from the first 
passage B16 Fl produced many fewer lesions when injected 
intravenously and are less lung selective. Using an 
identical method, cell lines with selectivity for liver 
(Tao et al, 1979) ovary (Brunson & Nicholson, 1979) and 
brain (Raz & Hart, 1980) have been identified. Further 
degrees of specific localisation within the central nervous 
system have also been described (Brunson et al, 1978). 
Clearly these experiments could be interpreted as 
supporting the hypothesis that primary tumours consist of 
heterogeneous clones some of which have specific organ 
colonising properties.
One feature of the B16 melanoma model which is most 
difficult to understand is the fact that ten or more 
passages were required to develop target organ specificity 
to its maximum degree. This suggests that an alternative 
explanation could be that organ selective growth is
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inducible by prior growth at that site. This latter 
explanation is somewhat unlikely in view of an experiment 
where B16 Fl cells were incorporated within small carrier 
beads which were injected intravenously and the cells 
allowed to form metastasis ( W  (co & Ousted, 1982).
After nine similar steps the resulting cells were 
re-injected without the carrier beads and found to have no 
greater cell affinity for lung than the original cell 
line. While making an inductive hypothesis less likely this 
does not really answer the original question concerning the 
number of passages required. Further evidence for lung 
specificity is seen when B16 FIO cells are injected into 
recipients which carry subcutaneous grafts of lung tissue. 
This results in the formation of tumour deposits in the 
graft (Hart & Fidler, 1980). This experiment also 
demonstrates the ability of B16 cells to survive passage 
through at least one capillary bed, before forming a 
tumour.
Although the FIO and Fl cell lines were derived from 
métastasés, it can be shown that in a given sample only a 
few cells are able to generate new colonies when injected 
into animals (Hill et al, 1984). This was demonstrated by 
growing clones to different sizes; cells derived from small 
clones produced many fewer lesions when reinjected than the 
same number of cells from large clones. Using these 
methods it was shown that the difference in the FIO and Fl 
cell lines was related to differing rates of generation of 
metastatic variants. Elucidation of the precise 
developmental pathways involved in this process would 
perhaps help to clarify the mechanism by which repeated
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passage led to the development of the site specific B16 
cell lines.
Leaving aside the question of the relevance of the B16 
model as a useful guide to behaviour of human tumours, it 
is clearly of interest to consider possible mechanisms at a 
cellular and molecular level for the phenomena described 
above. It would be reasonable to expect the differing 
properties of cell lines to be related to differences in 
their cell membranes. This was elegantly shown by the 
fusion of membrane vesicles produced by one cell line to 
viable cells of another line (Poste & Nicholson, 1980) 
which resulted in altered behaviour in vivo.
Attempts to demonstrate differences in membrane bound 
proteins by gel electrophoresis have not been very 
successful. Little difference has been shown between the 
proteins isolated from Fl and FIO cell lines (Nicholson et 
al, 1977, Warren et al, 1975). In the case of brain 
colonising lines increases were found in 90Kd and lOOKd 
glycoproteins as compared to the Fl cell line (Brunson et 
al, 1978), Raz and his co-workers (1980) have attempted to 
define membrane differences by a wide range of techniques. 
In this study high and low metastatic cell lines were 
similar with regard to patterns of cell surface carbo­
hydrates although some differences were seen in lectin 
binding. Differences were also found in the level of 5' 
nucleosidase in the membrane, but study of membrane lipid 
composition showed no significant differences. Selection 
of cells for resistance to agglutination by wheatgerm 
agglutinin produced a much less metastatic cell line (Tao & 
Burger, 1977). Thus it can be concluded that despite the
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demonstrable importance of membrane constituents in 
mediating differences in the metastatic behaviour of cells 
little progress has been made in understanding the 
molecular basis of this phenomenon.
A second approach to this question is to examine the 
adhesive properties and membrane-binding affinities of 
various cell lines. It was possible to isolate clones of 
B16 cells which had variable rates of detachment from 
plastic when incubated with EDTA (Briles & Kornfield,
1978). Cells which detached readily tended to form fewer 
tumours when injected intravenously. A similar result was 
seen with adhesion to a cellular substrate (Winkelhake & 
Nicolson, 1976). When adhesion to tissue sections was 
tested FIO cells were shown to have a markedly greater
binding affinity for lung than other cell lines (Netland & 
Zetter, 1984). Other differences in in vitro cell adhesion 
have been described using platelets (Gasic et al, 1973) 
lymphocytes (Fidler & Bucana, 1977) and endothelial cells 
( & Winkelhake, 1975).
In an attempt to further examine the problem of the 
relationship of the cell surface to in vitro and in vivo 
behaviour, monoclonal antibodies have been prepared against 
B16 cells (Vollmers & Birchmeier, 1983a) and selected for 
inhibition of plastic adhesion by the cells. Some of these 
antibodies appear to react specifically with a 40-50Kd 
antigen in B16 melanoma cells. These antibodies appear to 
have a significant effect in reducing metastasis in lung 
when cells were preincubated with antibody or the animal 
pretreated with antibody. These studies suggest that the 
behavioural changes may be the result of a subtle change in
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the membrane perhaps related to one protein. However some 
caution is required in interpreting these experiments as 
the effects of the antibody could have been due to steric 
hindrance of in vivo adherence rather than the inhibition 
of the function of the bound protein.
In addition to these studies of the cell surface and 
cellular adhesion, behaviour has been correlated with a 
number of other phenotypic characteristics. Using 
fluorescent staining for DNA content and membrane 
constituents, it was possible to detect and isolate a 
metastatic B16 variant using a fluorescence activated cell 
sorter (Lessin et al, 1982). Other correlations with 
metastatic potential include the cAMP content of cells, 
(Shepard et al, 1984) resistance to anthracyclene 
antibiotics (Raz, 1982) and the effects of host immunity 
(Thomson et al, 1983). The possibility of a feedback type 
of growth stimulation in B16 cells involving insulin-like 
factors and growth hormone has recently been raised (Bajzer 
et al, 1984). It will be of interest to see whether 
differences in the level of activity of this pathway are 
found in other cell lines.
A final important property of the Bl6 system which has 
recently attracted considerable attention is the ability of 
sub-clones of cells to modulate the behaviour of other 
clones. The metastatic phenotypes of the B16 FI and FlO 
are highly stable. This is seen by the widespread use of 
these lines by many investigators. Poste found that clones 
established from these lines were heterogeneous with 
respect to metastatic ability. The phenotype was highly 
unstable when further sub-clones were cultivated in vitro
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(Poste et al, 1981). This instability could be corrected 
by mixing sub-clones together. Furthermore the use of drug 
sensitive and resistant clones showed instability could be 
re-introduced by application of a selection pressure by 
drug treatment. The conclusion of these studies was that 
the cells in the primary cultures tend to interact in such 
a way as to produce stability. This effect is not confined 
to B16 clones alone. Stabilisation can occur when B16 and 
K-1735 melanoma cells are mixed (Poste et al, 1984): normal 
cells and cells from other types of tumour do not do this. 
An analogous effect has been seen in vivo. Clones isolated 
from pulmonary métastasés soon after injection have a 
similar metastatic potential when re-injected. This is not 
the case for clones obtained later which progressively 
diverge (Poste et al, 1982). This effect is enhanced in 
the case of spontaneous metastasis if the primary tumour is 
surgically excised (Poste & Grieg, 1982). As yet there is 
no information as to the mechanisms of these interactions. 
Clearly if this phenomenon is found to be a property of 
most malignant tumours it will have important implications 
for the treatment of cancer.
The various studies described above can be summarised 
as follows. After many years in culture B16 melanoma was 
found to be heterogeneous with respect to metastatic 
behaviour. In vivo selection yielded cells with specific 
organ homing properties. An important feature of this cell 
line may be its ability to generate new variants and this 
can be modulated in various ways. Despite extensive study 
there is little indication as to the molecular basis of 
these effects.
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To place this work in context the answer to the 
following questions should be sought. Are the properties 
which have been described peculiar to B16 melanoma and to 
what extent can they be regarded as artefacts of tissue 
culture ?
c) Systems which resemble B16 melanoma.
The experimental model which most closely resembles 
the B16 melanoma is the K1735 mouse melanoma. This tumour 
arose in a C3H mouse following ultraviolet irradiation. A 
similar method was used to that which demonstrated clonal 
heterogeneity in the B16 melanoma (Fidler et al, 1981). 
Twenty of twenty-two clones derived from the K1735 tumour 
differed in metastatic potential from the parental line.
The experiments were performed soon after the primary 
presentation of the tumour and have been used to counter 
the argument that the findings with B16 cells are an 
artefact of prolonged culture. Nevertheless the cells were 
grown in culture before the injection into the syngeneic 
hosts. Again following experiments performed with B16, 
K1735 induced lung nodules were used to derive new cell 
lines (Talmadge & Fidler, 1982). These were found to be 
more metastatic than the parent line following subcutaneous 
and intravenous injection and have been taken as supporting 
evidence of the origin of metastasis from distinct 
subpopulations of cells. As yet no attempt has been made 
to produce organ specific cell lines from K1735.
K1735 shares the obvious similarity with B16 of being 
melanocytic in origin. However tumours of other types have 
been studied in similar experiments. The UV-2237 
fibrosarcoma line has shown heterogeneity (Raz et al, 1981)
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after cloning as well as increased métastasés by cells 
derived from lung lesions. This line has also been used in
studies of clonal stability as described above for B16 and
has given similar results (Cifone & Fidler, 1981). The 3LL 
lung carcinoma cell line after two passages through lung 
also showed greatly enhanced metastatic potential (Talmadge 
& Fidler, 1982) . Thus it is reasonable to conclude that 
the type of heterogeneity demonstrated in B16 melanoma 
cells is not simply a peculiarity of this cell line since 
most of the essential features of the B16 model have been 
observed with other cell lines,
d ) Systems which do not show heterogeneity.
It would be wrong to assume that the results of the 
experiments described above were universally applicable or 
indeed necessarily relevant to the behaviour of most 
tumours. Using a nickel-induced rhabdomyosarcoma it was
found that cloned cell lines vary with respect to
tumorogenicity and metastatic potential as compared to the 
parent line (Sweeney et al, 1982). However, it was found 
that clones which colonised the lung extensively following 
intravenous injection produced few metastasis after 
subcutaneous implantation and vice versa. This divergence 
of experimental and spontaneous metastasis has been well 
demonstrated by Tarin and Price (1979) using spontaneously 
arising mammary tumours (due to vertical transmission of 
murine mammary tumour virus). The cells were isolated and 
re-injected intravenously without prior culture. In about 
one third of tumours lung colonisation occurred, despite 
the fact that these tumours almost never metastasise in 
vivo. A similar result has been found with another non-
2.-7
metastasising breast carcinoma (Williams et al, 1982).
From these experiments it can be envisaged that while 
heterogeneity in potential to grow at a distant site may be 
present the cells with high colonising ability may lack the 
characteristics required to leave the primary tumour.
A second major objection to the general applicability 
of B16 melanoma and similar models is a possibility of 
culture induced artefacts. The lability of cells in vitro 
is a well known phenomenon. In the case of B16 cells clonal 
instability with regard to colonising potential has been 
demonstrated to occur and the composition of cellular 
populations can affect this process (Poste et al, 1981).
In view of these objections a more meaningful experiment 
might involve spontaneous metastasis without in vitro 
passage of cells. This approach has been used to compare 
KHT osteosarcoma, B16 wild type cells, 3LL carcinoma and 
T241 carcinoma (Weiss et al, 1983). When minced metastatic 
tumour suspensions were used the KHT and B16 metastasis 
gave rise to more pulmonary lesions following subcutaneous 
injection than suspensions derived from primary tumours. 
However, the other cells lines did not show this effect. 
When excised fragments were used for implantation no 
significant difference was seen between the primary and 
secondary tumours. These authors also found that biopsy 
fragments from tumours of different ages and sizes did not 
vary in metastatic potential. These experiments do not 
support the idea that métastasés arise from specialised 
populations of cells. However, one criticism of these 
experiments stems from the common observation that tumours
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are morphologically heterogeneous and may consist of 
discrete zones of similar cells. It was found that the 
transplantation of small fragments resulted in much greater 
homogeneity of metastatic potential than the use of larger 
fragments (Fidler & Hart, 1981).
It will be apparent from the preceding discussion that 
a great deal of controversy and uncertainty surrounds the 
question as to whether or not the cells which form a tumour 
metastasis arise from a distinct subpopulation within the 
primary tumour. Given the doubts about repeated in vitro 
passage it is reasonable to conclude that the evidence in 
favour of the proposition is far from conclusive. It would 
be expected that cells derived from metastatic lesions 
without in vitro passage would give rise to increased 
numbers of metastasis. This has not been consistently 
demonstrated. There are however objections to this type of 
experiment as a valid test of the hypothesis. One of these 
takes the form that although highly metastatic 
subpopulations exist it is not necessary that an individual 
metastasis should arise from one of these. A further 
problem arises from the possible rapid generation of 
heterogeneity within the metastatic lesion itself. These 
possibilities are exceedingly difficult to test critically. 
These criticisms do not imply that this body of work should 
be discarded as a series of meaningless artefacts. 
Irrespective of whether they reproduce the situation in 
most tumours, model systems do offer considerable 
opportunity for the study of cellular mechanisms. An 
example of this is the organ homing capacity of various B16 
cell lines. This represents a rare opportunity to study
cellular positioning at a molecular level and would have 
implications beyond the field of tumour biology. Clonal 
subpopulation interactions and dynamic heterogeneity are 
other phenomena of wide interest. It is perhaps unfortunate 
that these broader biological implications should have been 
to some extent neglected in the quest to prove or disprove 
the hypothesis which is described above,
e) Genetic aspects of the process of metastasis.
The process of metastasis is complex and a highly 
aberrant form of behaviour. It is therefore pertinent to 
ask what changes in gene expressions have occurred to allow 
this to happen. The most obvious approach to this problem 
would be to attempt to induce metastasising behaviour by 
transfection of cloned sequences from a cDNA library 
produced from metastatic tumours. This method has been 
used with some success to demonstrate the oncogenic effects 
of the ras family of oncogenes (Land et al, 1983, Gibbs et 
al, 1985). Recently DNA from a metastasising tumour was 
transfected into Ha-ras transformed 3T3 cells. This 
resulted in metastasis following subcutaneous injection, 
the metastatic lesions containing a common human sequence 
(Bernstein & Weinberg, 1985). As yet the sequences have 
not been characterised. The paucity of experimental data 
of this kind is an indication of the difficulties involved 
in obtaining and utilising appropriate tissues. The effect 
of the Ha-ras oncogene itself on the metastatic potential 
of cells has also been investigated (Greig et al, 1985). 
Transfectants of NIH 3T3 cells containing HA-ras sequences 
were found to be highly metastatic following subcutaneous 
injection. However surprisingly the 3T3 cells which were
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used also produced tumours and metastasis albeit at a lower 
rate. This approach has been further developed (Muschell 
et al, 1985). These workers found that only the mutated or 
viral Harvey ras were effective in producing experimental 
metastasis. 3T3 cells in this study were non-tumorgenic. 
However these results were not repeatable in C127 
transformed fibroblasts. This led to the conclusion that 
Harvey ras may act in concert with other cellular genes.
It is clear that the study of genes involved in metastasis 
is only beginning and progress can be anticipated. The 
identification of the genetic basis of metastasis would 
rapidly lead to the solution of the problems of hetero­
geneity and metastasising subpopulations as discussed 
above.
In addition to the identification of specific genes 
involved in metastasis a second major question is the 
mechanism of genetic change which results in tumour 
progression. Again little is known about this subject.
One intriguing aspect of it is the question of in vivo cell 
fusion as a generator of genetic change. There is some 
evidence to suggest that fusion of neoplastic and normal 
cells occurs in vivo. Human tumours grown in the hamster 
cheek pouch acquire hamster characteristics (Goldenberg et 
al, 1974). More definitively, tumours grown in bone marrow 
chimaeras undergo fusion with marrow derived cells (Weiner 
et al, 1972). In the Bl6 model using drug resistant 
markers no evidence of fusion with normal cells was found 
although fusion with other tumour cells seemed to occur 
(Hart, 1984). Following in vitro fusion, metastasising 
ability persisted when metastasising/non—metastasising
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tumour cell hybrids were formed but not in metastasising/ 
normal cell hybrids. Suggestive evidence for a role for 
cell fusion in vivo in mediating progression was found 
using drug resistant markers and the karyotype studies in a 
variant of the MDAY-D2 murine tumour (Lagrade et al,
1983). Repeated sampling of the implanted primary tumour 
showed progressive loss of drug resistence markers and 
increasing mean numbers of chromosomes. Metastatic 
deposits derived from these tumours were found to consist 
of drug resistant hyperploid cells. Karyotypic studies 
suggested that these changes were the result of cell 
fus ion.
Thus it seems likely that cell fusion may be one 
mechanism of tumour progression. Karyotypic studies of 
fused cells in turn may yield information concerning the 
genetic basis of metastasis,
f) The phenotype of the metastasising cell.
The preceding discussion focussed on the question as to 
whether specifically metastasising clones could be 
identified within a primary tumour. It is apparent that any 
cell which establishes a colony in a distant organ must 
have first completed a complex series of steps. These 
include escape from the primary site, entry into the 
circulation, interaction with blood constituents and the 
immune system followed by lodgement and growth at the 
distant site. It is equally apparent that failure to 
complete any of these steps will effectively prevent the 
formation of metastasis. Thus a complementary approach to 
the study of the cellular biology of metastasis is to 
dissect the phenotypic characteristics which allow cells to
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behave in this way. Such characteristics form a diverse 
group and will be considered below.
g ) Changes in cell to cell attachment in malignant cells.
The anatomical basis for many cell to cell attachments 
is well known. This takes the form of adhesion 
specialisations of the cytoskeleton such as desmosomes and 
the cytoplasmic interconnections seen in gap junctions 
(Hertzberg et al, 1981). Despite these detailed anatomical 
studies little is known about the regulation of expression 
of these characteristics. Another facet of the question of 
cell to cell attachment has been described by Edelman,
(1983) in his description of cell adhesion molecules.
These molecules show a degree of tissue and temporal 
variation which may be important in embryogenesis.
Cell attachments have also been studied in vitro. This 
work mainly employs the techniques of cell aggregation or 
alternatively assessment of strength of binding to various 
artificial substrates or other cells in culture. Notable 
results of this type of study may include the demonstration 
of differential cell adhesion and sorting where cells of 
various types are mixed together (Alberts et al, 1983).
Studies of the changes in the cellular attachment of 
malignant cells has been exclusively studied in vitro.
This work stems from the observations of Coman (1953) which 
showed that the cells of malignant tumours were more easily 
detached. Since these early studies a very large volume of 
literature has been generated. Using B16 cells it was 
found that highly metastatic variants were less easily 
detached from plastic culture flasks by EDTA (Briles & 
Kornfield, 1978). In contrast no difference in EDTA
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sensitivity was seen in fibrosarcoma cell lines but poorly 
metastatic cells were more easily detached by enzyme 
digestion (Varani et al, 1980a). A correlation was also 
found between attachment of this type of tumour cell to 
endothelial cultures and lung trapping after intravenous 
injection (Varani et al 1980b). These studies suggest that 
increased adhesiveness correlates with metastatic 
potential, but it is not a universal finding (Bubenick et 
al, 1976, Dorsey and Roth, 1973). The complex nature of 
this relationship has been illustrated by studies of the 
kinetics of aggregation when 3T3 cells and their SV40 
transformed counterpart were compared: the relative 
adhesiveness depended on the shearing forces applied, the 
transformed cells being less adherent at low rates but more 
adherent at high rates (Elvin and Evans, 1982).
The molecular basis for many of these effects is not 
known with certainty. Most studies indicate the 
involvement of glycoproteins and glycolipids and in 
particular the carbohydrate moieties of these molecules.
For example, inhibition of glycosylation in B16 cells by 
tunicamycin alters adhesion and reduces metastatic 
potential (Irimura et al, 1981). Alterations of lectin 
binding and metastasis in a rat mammary tumour is dependent 
on the expression of a high molecular weight glycoprotein 
(Steck & Nicholson, 1983) and alterations in the glycolipid 
GM3 have been seen in Bl6 sublines (Yogeeswara et al,
1978). Anti-cell surface antibodies have also been used to 
study this question. One series of monoclonal antibodies 
inhibits in vitro binding to plastic of a range of cell 
lines (Vollmers & Birchmeier, 1983b). Other monoclonal
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antibodies prevent aggregation of hepatocytes by RAW117 
lymphoma cells and inhibit liver metastasis (Nicholson, 
1984).
It is apparent from this brief review that no 
definitive statement can be made about whether increased or 
decreased adhesion is a phenotypic correlate with 
metastasis. Both alternatives would be conceivable on 
purely theoretical grounds. All that can be said is that 
perhaps variation in some of the cell surface molecules 
which mediate in vitro adhesion is important in the 
malignant phenotype. There is no evidence that the 
particular molecules described play a part in the 
attachment of tumour cells to each other or to stromal 
elements in vivo. The main value of this type of 
experiment described above must be as a form of screening 
assay for detecting molecular events relevant to the 
expression of malignancy.
h) Relationship of metastasising cells to the basement 
membrane.
Basement membranes are a complex mixture of proteins 
and proteoglycans. The major protein components are the 
non-fibrillar Type IV collagen and laminin (Kefalides et 
al, 1979) the latter probably mediating the attachment of 
cells to the basement membrane (Terranova et al, 1980).
The basement membranes separate epithelia, endothelia, 
nerve and muscle from surrounding connective tissues and 
appear to be synthesised by these cells (Kefalides et al,
1979). During the process of invasion and metastasis the 
tumour cells must penetrate a number of basement membranes 
both surrounding their tissue compartment and around blood
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vessels. It is therefore relevant to ask whether the 
basement membrane surrounding tumour cells is defective and 
what mechanism tumour cells have for penetrating these 
structures.
Deficiency or poor formation of basement membrane is a 
common feature of malignant tumours. This can be 
demonstrated histologically, immunocytochemically or by 
electron microscopy. Studies which describe this as a 
feature of malignancy in breast and colon have been well 
documented (Siegal et al, 1981, Ozzella, 1959, Barsky et 
al, 1983 and Burtin et al, 1982). These findings could be 
due to either reduced synthesis of basement membrane or to 
dissolution by invading cells. Little information exists as 
to the former mechanism due to great difficulty in studying 
this in vivo.There is however some evidence to support the 
possibility that some tumour cells may degrade basement 
membrane. A distinct type of collagenase capable of 
digesting type IV collagen has been described (Salo et al,
1983). Correlation of the activity of this enzyme and 
tumour malignancy has been documented in a number of cases 
(Liotta et al, 1984, Starkey et al, 1984).
Attention has also focussed on the relationship 
between attachment to the basement membrane and 
malignancy. When B16 cells are selected for attachment to 
type IV collagen increased metastatic potential is found 
(Terranova et al, 1982). In this study in vitro binding to 
type IV collagen was mediated by laminin. In another study 
using B16 cells attachment to type IV collagen, invasion of 
amnion and pulmonary colonisation were enhanced by the 
addition of laminin but inhibited by fibronectin (Terranova
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et al, 1984), A cell receptor for laminin has been 
purified from a breast carcinoma cell line (Malinoff & 
Wicha, 1983). The number of receptors present appear to be 
increased in some malignant tumours (Liotta, 1984). 
Moreover, blocking these receptors by degraded laminin 
appear to inhibit metastasis formation (Liotta et al,
1984). These studies indicate that cells may attach to 
type IV collagen through a receptor and laminin. This 
simple model does not apply to all systems which have been 
studied. The murine line MDAY-D2 has given rise to 
non-metastatic WBA^ mutants. This mutant avidly bind to 
type IV collagen but not the laminin. A similar pattern of 
binding with abrogation of metastatic properties may be 
produced by neuraminidase treatment of the parent line 
(Dennis et al, 1982). In summary, malignant cells have a 
complex relationship to basement membrane with degradation 
and increased binding being features of the malignant cell 
phenotype. In theoretical terms it is possible to envisage 
how both these features could promote metastasis 
formation. Increased basement membrane binding serves to 
localise the digestive action of cells; it could also be a 
factor in trapping at distant sites.
i) Cell Motility and Contact Inhibition of Movement.
The mechanism of movement of cells in culture has been 
intensively studied (Abercrombie, 1982). The main elements 
a re the projection of lamellipodia and microspikes from the 
forward edge. Some of these attach to substrate others are 
swept backwards in the ruffling movement of the cell 
membrane. This process results in the attenuation of the 
q £ the cell which detaches and retracts into the cell
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body. These movements are functions of the cytoskeleton 
particularly the ray of actin filaments which form 
complexes with various protein most notably myosin ATPase.
Changes in cell motility are an obvious feature of 
metastasising tumour cells. Such changes could either 
occur at the cytoskeletal level with acquisition of ability 
to move, or alternatively at the level of control of 
movement. The demonstration of enhanced motility in vitro 
has generally involved the use of two compartment systems 
analogous to the Boyden chamber. The boundary may either 
be an inert membrane or a piece of tissue. Using a simple 
porous membrane and radio-labelled cells it was found that 
malignant cells crossed the membrane whereas normal cells 
did not (Hart & Fidler, 1978). This type of experiment has 
also been performed using human amnion (Easty & Easty,
1974) and chick chorioallantoic membrane (Russo et al,
1982) as a barrier. Fidler and Hart used mouse bladder as a 
boundary and were able to recover and propogate a highly 
invasive subline of the Bl6 melanoma from cells which 
crossed the bladder wall (Poste et al, 1980, Hart, 1979). 
This is known as the Bl6 BL6 line.
The question of how these changes in motility are 
related to alterations in cytoskeletal function are at the 
present time obscure. As adhesion is an integral part of 
this process some of the work described above may be 
relevant to this question. An alternative approach is to 
consider the factors which inhibit the movement of normal 
cells away from their primary sites. Again this question 
has been exclusively studied in vitro. The key concept is 
inhibition of movement which results from the contacts
38
between cells. An in vitro model which was used to 
investigate this concept is one in which an explant of 
normal tissue confronts a culture of tumour or normal 
cells. Three possible outcomes of this experiment have 
been described (Abercrombie, 1979, Abercrombie & Heaysmann,
1976). When normal cells are used their motility ceases 
when they reach fibroblasts migrating out of the explant. 
When malignant cells are used they penetrate deeply into 
the sheet of outwardly migrating normal cells, whose spread 
may or may not be arrested by contact with the tumour 
cells. This type of analysis has been repeated using a 
wide range of tissues and cell lines (Marcel, 1983).
There can be little doubt that the findings described 
above are highly reproducible features of tumour cells in 
culture. However, it is equally true that the assay 
systems used are of a highly artificial nature and 
extrapolation to in vivo situations is not possible, 
j ) The relationship between invading tumours cells and
surrounding connective tissues.
In order to metastasise tumour cells must have the 
ability to traverse surrounding connective tissue and enter 
lymphatic or blood vessels. In many human tumours it is 
apparent that tumour cells may have a profound effect on 
the connective tissues through which they are passing. 
Common examples include proliferation of fibroblasts and 
alterations in the components of the extracellular matrix, 
for example, collagen, elastin or proteoglycans and 
proliferation of endothelial cells to form new blood 
vessels. Similarly, when metastasising cells attempt to 
grow at a distant site the ability to stimulate the
39
connective tissue stroma would seem likely to be an 
important factor. The attempts which have been made to
study these factors in experimental systems will now be 
considered.
Much attention has focussed on the production of 
degradative enzymes which allow motile tumour cells to 
traverse dense connective tissue matrix. These enzymes 
include the metalloproteinases such as classical 
collagenase and proteoglycanases. Collagenase acts on type 
I fibrillar collagen at one site which renders the peptides 
susceptible to further breakdown by other enzymes (Murphy & 
Reynold, 1985). Type I collagenase has been found in a 
number of tumours (Dresden et al, 1972, Dabbous et al,
1977, Robertson & Williams, 1969). It has been shown at 
least in some cases that the level of production of type I 
collagenase correlates with the ability to form 
experimental metastasis (Tarin et al, 1982). Plasminogen 
activator is another example of a neutral protease which is 
detectable in some tumour cells. However, there is 
considerable uncertainty concerning the correlation of this 
enzyme with metastatic potential (Tarin et al, 1982, Wang 
et al, 1980, Nicholson et al, 1976). Other enzymes studied 
include elastase (Jones & De Clerck, 1980) Cathepsin B 
(Sloan et al, 1982) and proteoglycanases (Nicholson,
1982).Most of the work cited above refer to cultured cell 
lines. To attempt to study enzyme activity in tissue 
homogenates would be extremely difficult in view of the 
diversity of reactive cells which are normally present in 
tumours.
Fibronectin is a high molecular weight glycoprotein
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abundant in extracellular matrix and bound to cell surfaces 
(Yamada & Olden, 1978). Loss of this protein from 
transformed cells was one of the observations which led to 
its characterisation. Again there is some doubt as to the 
relevance of loss of fibronectin to metastasis with 
different results being obtained from various systems (Chen 
et al, 1976, Niemczuk et al, 1982).
Clearly there are distinctive parallels between these 
studies and the relationship of tumour cells to the 
basement membrane described above. However, as indicated 
the stromal reaction to tumour cells is much more 
complicated in vivo. Relatively little is known about the 
factors which could cause proliferation of connective 
tissue or changes in structure of the connective tissue 
matrix. In contrast the relationship of tumour cells to 
endothelial cells and blood vessels has been extensively 
studied. The importance of formation of new blood vessels 
to the process of metastasis has been demonstrated in a 
number of studies. The appearance of cells and cell 
aggregates in the venous effluent of an implanted tumour 
correlates with the formation and size of vessels in that 
tumour (Liotta et al, 1976). It was also found that the 
growth of tumour at distant sites depended on the growth of 
new vessels induced at that site rather than the 
reconnection of existing vessels (Folkman, 1975).
The formation of new blood vessels is a feature of 
the inflammatory response as well as the reaction to 
tumours. The process consists of the division of 
endothelial cells within existing vessels with penetration 
of the vascular basement membrane. The endothelial cells
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then invade as cords which later form a lumen. The final 
phase involves formation of a basement membrane and 
association with pericytes (Schor & Schor, 1983). It is 
possible that during this maturation phase vessels are more 
permeable to invading tumour cells but this is difficult to 
test experimentally.
Considerable efforts have been devoted to characterise 
factors from tumours or other tissues which stimulate 
angiogenesis. The starting point for most of these studies 
is the development of a bio-assay system. Examples include 
a rabbit ear (Brem & Folkman, 1975) rabbit cornea (Gimbrone 
& Guillino, 1976) and hamster cheek pouch (Greenblatt & 
Schubic, 1968). A convenient and inexpensive method uses 
the chick chorioallantoic membrane (Auspuink & Folkman,
1977). Most of these techniques involve the implantation 
of tissue or purified material followed by observation of 
the growth of new vessels. An alternative method involves 
the use of isolated endothelial cells in vitro (Folkman et 
al, 1979). These studies have produced no shortage of 
angiogenic factors. A number of low molecular weight 
factors (less than lOOOd) have been shown to produce 
angiogenesis in one or more of the systems described 
above. These include small copper binding molecules 
(McAuslan & Reilly, 1980) low molecular weight peptides 
(Feneslau & Wallis, 1982) and prostaglandins (Benezra,
1978).
Two high molecular weight substances should be 
particularly mentioned. The first is the lOOKd tumour 
angiogenesis factor first described by Folkman (1974). Its 
activity has been shown to reside in a group of heparin—
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binding endothelial mitogens (Shing et al, 1984, Esch et 
al, 1985). The significance of these substances is 
suggested by the apparent association of mast cells with 
angiogenic tumours (Kesler et al, 1976) and by the 
inhibitory action of the heparin antagonist protamine 
sulphate (Taylor & Folkman, 1982). Apparently distinct 
from these substances is the recently cloned and purified 
14 Kd protein known as angiogenin (Fett et al, 1985, 
Kurachi et al, 1985, Strydom, 1985). This substance does 
not bind heparin and is extremely active in the 
chorioallantoic membrane assay.
A third group of angiogenic factors are those related 
to coagulation. Fibrin degradation products are active in 
the chorioallantoic membrane assay (Thompson et al, 1985) 
and in addition, platelet derived growth factor is 
mitogenicfor endothelial cells in vitro (Seifert et al,
1984). The role of the coagulation system in metastasis 
will be further considered below.
The plethora of angiogenic factors and assay systems 
illustrate the complexity of the subject. However with 
progress in purification and sequencing of some of the 
factors some rationalisation will Inevitably take place.
It would be hoped that this would assist in answering a 
number of basic questions. Are multiple factors involved 
in the apparently stepwise process of angiogenesis? If so 
are tumour associated vessels defective as compared with 
those seen in a healing wound ? What contribution do 
tumour derived factors make to angiogenesis as opposed to 
those derived from inflammatory cells and coagulation 
factors ? As the answers to these questions may have
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considerable therapeutic significance it is likely that 
they will be pursued with vigour.
It is likely that the considerable recent expansion of 
interest in tissue growth factors (Rozengurt, 1983) will 
result in greater understanding of the tumour-induced 
growth of connective tissue components other than blood 
vessels. This will give a much more complete explanation 
of the relationship of tumours to stroma and its effect on 
metastasis.
k ) Circulation and Arrest of Tumour Cells.
Tumour cells which can detach from their primary 
tumour and traverse the surrounding stroma may gain access 
to lymphatics or veins and so enter the general 
circulation. The final destination of these cells will 
depend on haemodynamic factors and trapping of the cells in 
distant capillaries. Trapping in turn will be influenced 
by specific adhesion, the physical characteristics of the 
cell and extraneous factors such as the coagulation system.
Cytological examination of blood samples from mice 
inoculated subcutaneously with B16 melanoma and 3LL Lewis 
lung carcinoma showed that despite temporal fluctuations 
the carcinoma cells were able to enter the blood stream at 
a higher rate than Bl6 cells (Glaves, 1983). Although this 
was reflected in the development rate of metastasis, the 
number of circulating cells exceeded the final number of 
tumours by a very large margin. This and other studies 
(Butler & Gullino, 1975, Weiss, 1980) testified to the low 
efficiency with which circulating cells are able to 
generate metastasis. Clearly the majority of cells are 
injured or destroyed in the circulation. This could be
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caused by the immune system or cells could sustain 
mechanical injury while in the circulation. With one cell 
line, passage through a capillary bed reduced the ability 
of cells to form tumours to almost zero (Sato & Suzuki, 
1976). If the arrest of radiolabelled cells is measured 
little radioactivity remains in the body after a few days 
(Weston et al, 1974). Removal and culture of the lungs of 
animals after injection of tumour cells produces few viable 
tumour cells after 24 hours (Hewitt and Blake, 1975). Thus 
it appears that tumour cells are ill-adapted to the 
circulation and that this is important in limiting the 
development of metastasis.
The factors which may determine the growth of cells at 
specific sites are discussed above in relation to the Bl6 
melanoma. However the tendency for a tumour cell to lodge 
in a capillary bed may be related to simple physical 
characteristics rather than the presence of receptors which 
mediate site-specific adhesion. In some systems 
neutralisation of charge either with cations (Hagemar,
1972) or by enzyme treatment (Proctor et al, 1976) 
increased the general tendency for spontaneous metastasis 
to form. However, this is not always the case (Sinha & 
Goldenberg, 1974). Another possible factor is the ability 
of tumour cells to deform in order to resist the 
destructive effect of shearing forces (Sato & Suzuki,
1976) .
Aggregation is a further factor which could also 
influence the trapping of cells within the vasculature. The 
ability of Walker 256 carcinoma cells to form aggregates 
with platelets has been demonstrated (Warren, 1974).
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Clearly such aggregates could effect trapping by virtue of 
size or by more specific adhesion perhaps to exposed 
basement membrane. This idea is corroborated by the 
decrease in metastatic lesions seen in thrombocytopenic 
animals (Gasic et al, 1968). In some but not all systems 
treatment with anti-platelet drugs reduces metastasis
formation (Gasic et al, 1973). There is also some evidence 
that tumour cells differ in their interaction with 
platelets and that this may correlate with metastatic 
potential (Grignani et al, 1983). These observations 
suggest that platelets may influence metastasis formation 
in some types of tumour. Considerable attention has also 
been devoted to studying the role of fibrin formation in 
metastasis mainly by the use of anticoagulant drugs either 
to inhibit coagulation or to cause defibrinogenation. Some 
studies using Coumadins (Ryan et al, 1968) heparin (Suemasu 
and Ishikara, 1970) or snake venom (Wood & Hillgaard, 1973) 
have reported decreased metastasis whereas no effect was 
seen with other tumours (Hagemar, 1970). These results 
need to be interpreted with some caution in view of the 
multiple effects of some of the agents used.
In summary the stages of the metastatic process which 
involve local invasion and circulation of tumour cells are 
highly complex and poorly understood. However the studies 
described above serve to illustrate many of the non­
specific determinants as well as the specific phenotypic 
features which affect the ability of cells to metastasise.
1) The host reaction to tumours.
A major theme in the experimental study of metastasis 
is the concept that host defences exist and that metastatic
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cells may possess phenotypic characteristics which overcome 
such defences. The literature pertaining to this subject 
is vast and a comprehensive summary is not possible here. 
Three phenomena will however be considered. These are T 
lymphocyte reactions, natural killer cell reactions and 
cytotoxic macrophage reactions. All of these cells have 
effects in one or more model metastatic systems.
The T-lymphocyte response here will be taken to mean 
antigen-specific MHC class I restricted cytotoxicity. 
Evidence is lacking that the majority of tumours express 
novel antigens which are potential targets for a T 
cytotoxic response, but such antigens are found in some 
systems. The most commonly reported example is the 
polymorphic tumour-specific antigens of methylcholanthrene- 
induced fibrosarcomas and other tumours (Old et al, 1962). 
When tumour cells of this type are injected into syngeneic 
animals few tumours are seen, but the incidence is greatly 
increased if the host animal is immunosuppressed (Woodruff 
et al, 1984a, Woodruff et al, 1984b), In contrast, 
treatment with the T-cell suppressant cyclosporin A has 
little effect on epithelial tumours which are poorly 
immunogenic (Eccles et al, 1980). In the methylchol- 
anthrene induced fibrosarcoma, the primary tumours may be 
removed after a short period of growth but metastasic 
deposits continue to present for long periods after surgery 
(Fisher et al, 1983, Gorelik et al, 1981). Combined 
treatment with specific tumour—related antigen and cyclo­
phosphamide help prevent metastasis formation in this 
situation although neither are effective when given alone 
(Nomi et al, 1984). The Eb/Esb lymphoma model, also
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chemically induced, has been shown to spontaneously 
generate highly metastatic variants which are resistant to 
iü— vitro lysis by cytotoxic T-cells reacting against a 
tumour associated transplantation antigen (Bosslet & 
Schimmacher, 1982). The fusion of Esb immunogenic cells 
with normal T-lymphocytes sometimes decreased 
immunogenicity and results in growth and metastasis in 
immunocompetent mice (Larizza et al, 1984). A third 
example which has been studied is a chemically induced rat 
mammary carcinoma. In this system immunisation with killed 
cells retards the growth of poorly metastasising tumours 
suggesting that they are immunogenic whereas this does not 
occur with highly metastatic types(Kim, 1970). Non­
metastatic tumours of this type also evoke much greater 
degrees of reactive, lymphoid hyperplasia than more 
malignant variants (Yao et al, 1983).
These studies show that some tumours may be antigenic 
and that there may a good correlation between growth of 
metastasis and the absence of antigens capable of eliciting 
an immune response, although the precise details of 
response is seldom well-characterised. There is however, 
no definitive evidence that such mechanisms are frequently 
found in systems other than chemically induced tumours in 
rodents.
The second possible mechanism of host defence against 
metastasis is non-antigen dependent cytotoxicity, most 
notably in the form of natural killer cells (NK cells). NK 
cell activity is usually demonstrated by the cytotoxic 
action of spleen cells on a YAC-1 cell target without prior 
sensitisation (Gorelik & Haberman, 1981, Gorelik et al.
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1984). This activity is sometimes divided into two types 
depending on the time of lysis of target cells, the 
prolonged reaction being described as natural cytotoxic 
activity (NC activity) (Stutman et al, 1978). These 
activities have a number of relatively constant 
characteristics. They increase with age (Keissling et al,
1975) and can be inhibited by treatment with cyclo­
phosphamide (Mantovani et al, 1978) beta-oestradiol (Seaman 
et al, 1978) and antibodies against asiaolo GMl (Kasia et 
al, 1981). The cells responsible appear to be a subset of 
the large granular lymphocyte seen in peripheral blood 
(Moore, 1985). These cells express the T8 (T suppressor/ 
cytotoxic) determinant and respond to interleukin II 
(Moore, 1985). Recently the beta T cell receptor gene has 
been shown to be rearranged in cells with NK activity 
(Yanagi et al, 1985). They have also some features of 
cells of the mononuclear phagocyte system (Moore, 1985). 
These features of differentiation, which hitherto seemed 
incompatible, are also seen in the T-gamma leukaemia 
described by Kadin (1981) which may be a tumour of NK 
cells.
A number of observations suggest that a non-antigen 
driven mechanism may in some systems be protective against 
the formation of metastasis. Nude mice which have minimal 
T-cell activity have significant NK activities which 
increase with age (Hanna, 1980). Metastasis in these 
animals is rare but can be induced by the agents described 
metastasis can be abolished by transfusion with lymphoid 
cells bearing NK activity around the time of tumour cell 
inoculation (Hanna & Fidler, 1980). Finally, when UV2237
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fibrosarcoma cells are co-cultivated with syngeneic spleen 
cells the survivors are more metastatic although they are 
identical to parent cell line in every respect other than 
NK cell binding (Hanna & Fidler, 1981). Similar results 
have also be obtained using clones derived from the 3LL 
tumour (Segal et al, 1982). In the context of the 
preceding discussions a number of observations concerning 
the recognition of tumour cells by NK cells are relevant. 
In a number of cell lines laminin binding appears to be 
correlated directly with sensitivity to NK cells (Hiserodt 
et al, 1985). Addition of laminin inhibited cell killing. 
The effect was specific for laminin and did not influence 
immunocytolysis. It has also been suggested that the 
antimetastatic effects of NK cells in vivo may be blocked 
by fibrin (Gorelik et al, 1984) as shown by an apparent NK 
cell anticoagulant synergism. These observations raise 
more general questions as to the mechanisms of NK cell 
recognition of tumour cells. Clonal analysis suggests that 
NK cells recognise only a few specificities unlike T-cells 
(Moore, 1985). Several suggestions as to a receptor have 
been made such as the glycolipid asialo GM2 (Young et al, 
1981) and the transferrin receptor (Newman et al, 1984) but 
no consensus has been reached on this matter.
In addition to the antigen responsive lymphocytes and 
NK cells, macrophages represent a third possible mechanism 
of host lysis of tumour cells. Reactive macrophages are 
commonly found in human tumours. This may take various 
forms such as an infiltrate between neoplastic cells or 
sinus histiocytosis or granuloma formation in nearby lymph 
nodes. However, in comparison with the other cells
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described above the role of macrophages in experimental 
tumours is less clearly defined. One of the difficulties 
in studying this problem is that macrophage activity is 
modulated by T—lymphocytes and that T-lymphocytes depend on 
macrophages for antigen recognition. It has also been 
suggested that macrophages may modulate NK cell activity 
(Djeu et al, 1979a, Djeu et al, 1979b).
Isolated macrophage populations have been shown to 
kill some types of tumour cell in vitro (Cohen et al, 1982,"), 
Poste et al(1979) have shown that treatment of animals with 
lung homing liposomes containing macrophage activators is 
effective in reducing the number of B16 lung metastasis. 
When the density of macrophages within lung metastasis was 
measured it was found to be highest in early lesions 
declining rapidly as the tumour grows (Bugelski et al,
1985). It has been suggested that this may be evidence for 
a tumour escape phenomenon.
It is apparent from this brief discussion that host 
cell responses to tumours have been clearly shown to 
prevent metastasis in some types of experimental tumours. 
However, it is far from established that these mechanisms 
have general applicability especially in human 
tumours. Attempts to identify tumour specific antigens in 
human tumours have not been very successful and in the 
absence of these it is difficult to make a case for antigen 
dependent immune responses. The evaluation of NK cell and 
macrophage functions will be greatly simplified when the 
recognition mechanisms of these cells are better 
understood.
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m) Local regulation of growth.
The final stage in the metastatic process involves 
growth of cells at a distant site. Cells may reach a 
tissue, remain viable but fail to grow. This is the 
phenomenon of tumour dormancy which has already been 
described as it occurs in human tumours. Clearly this 
could involve either systemic repression of tumour growth 
or it could be confined to a particular site.
From experimental work a number of mechanisms have 
been postulated to account for this phenomenon. They can
be divided into absence of growth factors (or presence of
inhibitors) at a particular site or the growth inhibitory 
effect of the immune system.
Tissue growth factors are now being identified and 
characterised, but as yet there is little understanding of 
their precise physiological role. The involvement of such 
factors in the regulation of tumours however can perhaps be 
inferred by the effect of local operative trauma on the 
activation of dormant Walker 256 cells. (Fisher & Fisher, 
1959). Similar activation occurs when oestrogen is
administered to castrated animals bearing oestrogen
dependent tumour cells (Noble & Hoover, 1975).
The possible effect of the immune system on tumour 
suppression can be demonstrated using animals from which a 
primary tumour has been excised. Activation of dormant 
cells can be achieved by the use of systemic immuno­
suppression (Eccles & Alexander, 1975, Alexander, 1982) or 
by transplanting a lung to an immunosuppressed animal 
(Alexander, 1983). Cells induced to grow in this way are 
apparently similar to the original primary tumour (Eccles
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et al, 1980). These experiments do not give an indication 
as to the mechanism by which the immune system is able to 
suppress growth and its relationship to other cytotoxic 
effects on human cells .
Another approach to this problem is to attempt to 
modify tumour growth by modifying the host tissue before 
induction of tumour. This is illustrated by the effect of 
local irradiation on the growth of metastasis at a given 
site, an effect which is unexplained but appears to be 
independent of immunological mechanisms (Peters et al,
1978, Milas et al, 1983, Wither & Milas, 1973). It could 
relate to post-injury regeneration or vascular changes. 
Irrespective of the mechanism, these experiments suggest 
the need for caution in the interpretation of experiments 
in which radiation is assumed to act as an immuno­
suppressive agents in promoting tumour growth.
The preceding discussion is not an exhaustive account 
of tumour metastasis but serves to demonstrate the great 
complexity of this process. The remainder of this thesis 
will examine in greater detail some of the factors which
regulate the growth of tumour cells at distant sites. Most
of the work described will utilise experimental metastasis 
(intravenously injected tumour cells) to circumvent the 
complex problems of local invasion, angiogenesis etc. The 
questions to be considered include the role of the
vasculature in determining the site at which a tumour cell
will grow, and the effect which growth at a particular site 
has on the subsequent behaviour of tumour cells. In 
Chapter 3 the role which histocompatubility antigens may 
play in mediating this type of cellular interaction will be 
considered.
CHAPTER TWO
The effect of Intraperitoneal Passage on the behaviour of 
B16 melanoma and mouse salivary tumours cells.
53
CHAPTER 2 
2.1. Introduction 
This chapter will consider some of the factors which 
determine where a metastasising tumour will grow. The 
derivation and behaviour of the B16 melanoma cell lines has 
already been discussed. The FIO cell line was the result 
of 10 cycles of intravenous injection and passage of the 
resulting pulmonary metastasis. This produced a population 
of cells which is highly metastatic and selective for 
growth in the lung (Poste & Fidler, 1980). The FI cell 
line is the result of one such passage and is poorly
metastatic and less selective in its sites of growth. The 
behaviour and mode of derivation of the cells raises a 
number of important questions. Firstly, it is important to 
consider whether the cells used in these experiments show 
identical properties to those described in the original 
description of the B16 melanoma. This is important in view 
of the long period during which these cell lines have been 
maintained in culture. Secondly, is the characteristic 
behaviour of the Fl and the FIO cells a reflection of 
interactions with blood vessel endothelium or does it 
reflect differing abilities to grow within particular 
tissues ? Thirdly, as the FIO cells were derived by 
exposure to lung tissue is it possible to reverse the lung 
homing behaviour by exposing the cells to a different 
tissue environment? As the Fl cells are relatively 
unselected, can growth and passage at a particular site 
result in tissue trophism if the cells are not exposed to 
vascular endothelium ? Answers to these questions will be 
sought by examining the behaviour of FIO and Fl cells when 
grown in the peritoneal cavity.
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The B16, Fl and FIO cells are derivatives of a 
malignant tumour some variants of which at least are able 
to spontaneously metastasise. To consider the question of 
the effects of distant sites on tumour growth it is of 
interest to consider a tumour which does not spontaneously 
metastasise. Such behaviour could be due to failure to 
invade the circulation by any of the steps in the 
metastatic process described in Chapter 1, but equally, it 
is possible that benign behaviour may be the result of 
inability to grow at a distant site. This possibility will 
be tested by direct transplantation of cell suspensions and 
fragments of a benign salivary gland tumour to a distant 
site thus excluding the effects of earlier steps in the 
metastatic process.
The correlation between cell adhesion and local 
invasion/ metastatic potential has been discussed in pages 
32 n^,d 33. Little, however, is known about the relation­
ship between in vitro adhesion of tumour cells to a given 
tissue and the ability of cells to grow at that site. It 
has been shown that B16 FIO cells adhere more avidly to 
lung cryostat sections than to other tissues (Netland & 
Zetter, 1984), but no comparison was made with other B16 
lines, a lymphoma cell line being used as the control. An 
attempt will therefore be made to directly compare the FIO 
and Fl cells in this type of assay and to observe whether 
changes in cell adhesion occur in parallel with changes due
to in vivo passage. Allied to this study, the adhesiveness 
of the benign salivary tumour will be compared with its in_
vivo growth pattern.
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MATERIALS AND METHODS
a ) Cell culture methods.
1. Source of cells.
B16 FIO cells were obtained from the American type 
culture collection, Bethesda, Maryland. These were 
initially derived from the laboratory of Dr. I.J. Fidler 
(M.D. Anderson Hospital and Tumour Institute, Houston, 
Texas).
B16 Fl cells were kindly donated by Dr. C. Evans 
(Department of Experimental Pathology, University of St. 
Andrews). This line was also derived from Dr. Fidler's 
laboratory.
Both lines had been maintained in serial in vitro 
culture since their derivation about fifteen years ago.
2. Media
All experiments were conducted using the same media. 
Cells were grown in Hepes buffered Ham's FIO (Glasgow 
variant) (Gibco Ltd, Paisley, U.K.) containing 10% foetal 
calf serum, pH being adjusted using sodium bicarbonate 
solution. Other additives included Tryptose phosphate 
broth, L-glutamine and an antibiotic mixture (Penicillin G, 
Amphotericin B and Streptomycin). This medium was chosen 
after a number of preliminary experiments since it appeared 
to give the most rapid cell growth. It will henceforth be 
referred to as medium A (see Appendix 1).
When cells were being frozen for storage the same 
medium was used but with 20% foetal calf serum and glycerol 
(1:20 v/v) added as a cryoprotective agent (medium B) (see 
Appendix 1). When cells were being prepared for injection, 
final washing and resuspension was in minimum essential
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medium (MEM) without the addition of foetal calf serum.
3. Storage and use of cells.
To ensure reproducible results a large frozen stock of 
cells was maintained. Cells were replaced from stock every 
two to three months.
Cells to be frozen were suspended at 4 - 5 x 106 
in medium B. The vial was placed in a solid polystyrene 
block which was then left for five to six hours at -80°C 
before the vial was transferred to a storage unit. Long 
term storage was at -80°C. Stored cells were rapidly 
defrosted immediately centrifuged, washed and resuspended 
in medium A. Adherent cells were visible at 12 hours and 
growth was usually observable after 48 hours.
4. Handling of cultured cells.
Stock cultures were plated at 0.5 x 106 to 1 x 106 
cells per 80cm2 flask. A typical growth curve is shown in 
figure 2. Growth rates for both cell lines were relatively 
constant and predictable. Cells were removed from flasks 
as follows. Medium was removed and the growing surface was 
washed in Hepes saline (see Appendix 1 ) . VE ml of 10-5m . 
EDTA was added for one minute, most of which was then 
discarded. The flask was returned to the incubator for 2 - 
3 minutes. It was then shaken vigorously for a few seconds 
until all the cells had been detached.t^nCml of medium A was 
then added and cells were washed, counted and resuspended.
Cells for injection into animals were prepared as 
follows. Cultures were used 3 - 4  days after subculturing. 
These cultures were sub—confluent at this time. Preliminary 
experiments suggested that later cultures were sometimes 
less predictable in terms of in vivo behaviour. Only
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adherent cells were used, detached cells and membrane 
vesicles (frequently present in the media) being 
discarded. All suspension for injection were used at a 
concentration of 106 cells ml~l.
5. Characterisation of B16 cell lines.
To ensure that cell lines were still melanocytic and 
not contaminated with fibroblasts following in vivo passage 
the following procedure was adopted. Cells were removed by 
EDTA as described and added to a Petri dish containing a 
sterile coverslip and 2-3 ml of medium A. After two days 
the coverslips were removed and fixed in Wolman's fixative 
for 30 seconds, then briefly washed in distilled water. 
Coverslips were then stained with haematoxylin and eosin or 
by Schmorl's method for melanin. To show evidence of 
melanin synthesis the dopa method was used. Coverslips 
were incubated in a solution of Img of 3, 4 dihydroxy
phenylalanine in phosphate buffered saline pH7.4 for 30 
minutes. This solution was changed and incubation was 
continued for a further 2 hours at 37“C. As a control, 
coverslips were incubated with buffer alone. A positive 
reaction was seen by the presence of dense brown granules.
6. Comparison of in vitro growth of B16 cell lines.
Cell suspensions of Bl6 FIG and Fl and passaged FIO 
and Fl cell lines were added to 8 - 10 replicate 25 cm2 
flasks at a concentration of 2 x 10  ^ medium.
After 7 days, without change of medium, the cells were 
completely removed and counted. The cell lines were 
compared for cell yield using Student's t-test.
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b. Conduct of animal experiments
1. Source of animals
All the experiments described in this chapter 
involving B16 cells used C57 BL6 mice: this is the 
syngeneic strain for the B16 melanoma. Breeding stocks of 
this strain were obtained from Olac Limited. Experimental 
animals were bred as follows. HfA brother/sister breeding 
pairs were maintained as a core stock. These were replaced 
by their own offspring as required. The progeny of this 
core stock were randomly mated for up to two generations.
The induction of salivary gland tumours was carried out 
using CFLP strain mice. These were derived from a colony 
which has been maintained for many years in Glasgow Royal 
Infirmary. These mice were not inbred.
2. Utilisation of animals.
Preliminary experiments with the B16 melanoma showed 
no difference between male and female animals with respect 
to tumour growth. Therefore both sexes were used, animals 
being randomly allocated to experimental groups. This was 
essential for reasons of economy and limitations on the 
size of animal colonies. In all experiments the animals 
used were 6 - 9  weeks of age. Again, this was the 
narrowest feasible age range. Breeding and experimental 
animals were housed at 21°C in a 12 hour light dark cycle. 
Water was freely available and the diet was the same 
throughout the study (CRM nuts K.K. Gruff, Croydon).
3. Injection techniques.
Intraperitoneal injections were performed using a 2Ig 
needle. In most cases 2 x 10^ cells were injected in 0.2 
ml of Minimal Essential Medium (MEM - Gibco Ltd).
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Intravenous injection was performed using a 27g 
needle. The animal was immobilised in a specially designed 
holding cage. The tail was swabbed with vv\lene which 
produced venous dilatation within a few seconds. The 
needle was introduced into the tail vein freehand. It was 
readily possible to determine whether fluid was freely 
passing into the vein by resistance to the syringe 
plunger. Animals in which observable tissue swelling 
occurred were discarded. In animals used in experiments 
tumours at theinjection site were never seen. In 
preliminary experiments,the femoral vein was exposed and 
injected under general anaesthetic. However no advantage 
was found in using this method which was very time 
consuming. In most instances 0.2ml of cell suspension was 
injected. When groups of animals were being injected 
random samples of cells were smeared and stained to check 
for clumping but this never happened to a significant 
extent. In all cases more than 95% of injected cells were 
viable as determined by the trypan blue exclusion test.
4. Assessment of tumour growth,
i. Following intravenous injection.
The growth of tumours in lung was assessed 12 days 
after injection of cells in all experiments unless 
otherwise described. Two methods of assessment were 
initially compared. Lungs were removed and examined using 
X 40 magnification of a stereo microscope. All pleural or 
sub-pleural deposits visible at this power were counted.
The same lungs were then fixed in formalin and paraffin 
embedded. Multiple levels were cut and the relative area 
of tumour measured by point counting using a semi—automated
60
system. (Northstar Advantage microcomputer with magnetic 
digitising tablet used in conjunction with a microscope and 
camera lucida). Fields and sections were counted in each 
case until the running mean fluctuated by less than 5%. A 
regression analysis was performed for the two methods which 
showed a close correlation (Fig. 3), The former method was 
chosen because of simplicity and similarity to the method 
used by most other workers with this model.
In addition animals were examined macroscopically and 
by random histological sampling for tumour deposits in 
other organs.
ii. Intraperitoneal injection.
Animals were examined at 5 days after injection. As 
both cell lines grew very rapidly at this site early 
sampling was required to prevent confluence of deposits and 
death of animals, which was almost 100% after 9 - 1 0  days.
Preliminary experiments showed that tumour deposits 
were most constant in the mesentery and visceral peritoneum 
of the small intestine. To quantitatively compare animals 
the small intestine was excised from the gastroduodenal 
junction to ileocaecal valve. The mesentery was then 
detached along its root. This specimen was cut into 1cm 
lengths and examined at x 40. All visible tumour deposits
were counted.
Animals were routinely examined at post mortem and 
histologically sampled (particularly lungs). However, 
following intraperitoneal injection of cells distant 
metastatic deposits were never seen throughout the study.
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5. Measurement of tumour cell trapping» (Appendix 2)
Cultures of B16 melanoma cells were prepared as above. 
hours before use the medium was changed and replaced by 
medium A containing 3 MBq/lOOml of Na 51cr (Amersham).The 
following day cells were removed and washed twice in MEM 
and then resuspended as before.
It was found that after 24 hours the cells were 
sufficiently labelled for convenient measurement. To 
examine the retention of 51cr replicate cultures were 
prepared and labelled as described above. After 24 hours 
the radioactive medium was removed and replaced by normal 
medium. Cultures were then harvested at various times and 
radioactivity counted in 2 x 10^ cells using an LKB gamma 
counter with a 010-450KV window setting. The half life of 
the isotope retention was calculated from these 
measurements by fitting an exponential curve using 
regression analysis.
Animals were injected intravenously with 0.2 ml 
containing 2 x 10  ^ radioactively labelled cells. Animals 
were killed 2 and 4 hours after injection. The lungs were 
removed, the heart was detached and the lungs were placed 
on filter paper to absorb excess blood. The lungs were 
then weighed and the radioactivity was measured by placing 
both lungs in a counting vial. The results were calculated 
as follows. The radioactivity per gram of tissue was 
calculated. To correct for the variable labelling of 
different cell samples this value was then divided by the 
radioactivity in 0.1ml' of the cell suspension. The final 
result was multiplied by 1000 for convenience in analysis.
In the following text all values referred to as cpm/g are
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corrected in this way. Comparisons between groups of 
animals was made using Student's t-test.
c ) 1. Serial transplantation of B16 melanoma cell lines.
B16 Fl and FIO cells were injected into the peritoneal 
cavity. The number of lesions arising were counted as 
described previously. The number of tumours produced by 
two cell lines were compared using Student's t-test.
In an attempt to modify the behaviour of these cell 
lines serial passage was performed through the peritoneal 
cavity. This was carried out as follows. Animals were 
injected by 2 x 105 cells and kept for 5 - 6  days. They 
were then killed and the abdomen was opened aseptically. A
number of tumour deposits were then excised and placed in a
sterile Petri dish containing MEM. The lesions were 
chopped and disrupted by repeated pipetting. After washing 
twice in MEM the cells were then re-injected into the 
peritoneal cavity of a new group of animals. This 
procedure was then repeated. The cells derived from these 
intra-abdominal passages were established as new lines in 
culture. Finely chopped disaggregated fragments were 
placed in 2 5cm flasks together with 5ml of the medium A. 
After 24 hours the medium was changed to remove debris and
the cells left to grow.
In the case of later passages of Fl cel Is numbers of
cells and longer incubation periods were required (see
Results section below).
2. Assessment of the effects of passage.
Cultured cells derived as above from various passages 
of both Fl and FIO cells were injected intravenously and 
intraperitoneally into groups of C57 BL6 mice. The methods
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used were identical to those described in pages 59 and 60. 
The number of tumour deposits arising was compared with the 
original cell lines using Student's t-test. The use of 
cultured rather than freshly isolated cells was essential 
here to ensure a single cell suspension and freedom from 
toxic cellular debris before intravenous injection.
The trapping of Fl cells passaged through the 
peritoneal cavity 16 times was assessed as described above 
using 51Cr labelled cells. The degree of lung trapping was 
compared with unpassaged Fl cells using Student's t-test.
d) 1. Induction of salivary tumours.
Tumours were induced using mouse polyoma virus which 
was a gift from Dr. P. Lamey, Glasgow Dental Hospital. The 
virus was prepared at a concentration of 109 plaque forming 
units (pfu) per ml.
After preliminary experiments it was found that CFLP 
mice formed tumours ^  the highest frequency and these were 
used in the remainder of experiment. Newborn mice (within 
24 hours of birth) were subcutaneously injected in the neck 
region with 25 pi of virus suspension and then returned to 
their mother. The animals were weaned at six weeks and 
observed for evidence of tumour development.
2. Transplantation experiments.
The aim of these experiments was to examine whether 
salivary tumours grew at a distant site following 
transplantation. As the CLFP strain is not inbred it was 
decided that all transplantation procedures using these 
mice should be performed as autografts. Tumours were 
excised as follows: t-uimour bearing mice were anaesthetised
with ether. A midline incision was made over the tumour
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and the skin reflected, the tumour was mobilised by blunt 
dissection and as much removed as possible without causing 
excessive haemorrhage. When haemostasis was secured the 
wound was closed using black silk sutures.
3• Preparation of cell suspensions from Salivary Tumours.
Tumours excised as above were placed in a sterile 
Petri dish containing a small volume of MEM. The tumour 
was finely diced using two pairs of sterile scissors. The
larger fragments were then removed and the remainder 
aspirated into a syringe and forced through a 19g needle 
several times to further disaggregate the cells. The 
resulting suspension was centrifuged and washed twice in 
fresh MEM. Viability of the cells were checked by 1% 
trypan blue exclusion and a final suspension of 5 x 106 
cells ml-1 prepared.
Fragments of tumour were prepared for transplantation 
by chopping the tumour with scissors and selecting 
fragments of approximately 1mm3 in size.
Cell suspensions were injected directly through the 
abdominal wall of the animal from which they were 
obtained.Fragments were transplanted into the peritoneal 
cavity through a small incision made under general 
anaesthesia. This was closed with a single silk suture.
Animals were kept for a minimum of 4 weeks. They were 
then killed and thoroughly dissected. The peritoneal 
cavity was inspected under a dissecting microscope for 
evidence of tumour deposits. Lesions found were sampled
histologically.
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e) Assessment of in vitro cell adhesion.
1. B16 cells.
Cryostat sections were used as substrates to test the 
relative adhesiveness of passaged and unpassaged FIO and Fl 
cells.fivA2pm sections were cut from C57 BL6 liver, lung and 
FIG and Fl tumour masses grown in the peritoneal cavity. 
Pieces of parietal peritoneum were excised and rolled 
around a sliver of wood. This was snap-frozen and sections 
cut tangentially.
Cell suspensions were prepared as described above. The 
cryostat sections were air-dried and 200pl of cell 
suspension (106/ml) added to cover each section. After 
incubation at 4“C for 2 hours the sections were washed for 
5 minutes in tris buffered saline, fixed in Wolman's 
fixative and stained with H & E.
The area of each section was measured using the same 
semi-automated morphometry system as described on page 
The number of cells adhering to the sections were counted 
and expressed as cells per mm2. Holes in the section were 
subtracted from the area and cells not adherent directly to 
the tissue were not counted. sections were measured for 
each tissue with each cell type. A few sections in which 
large numbers of cells were adherent to the glass slide 
surrounding the section were excluded. The final result 
was expressed as cells adhering to lung, liver or 
peritoneum divided by the average number adhering to the 
section of autologous tumour.
2. Polyoma salivary tumour cells.
The protocol used was essentially similar to that
described above. As the tumour cells could not be
66
successfully cultured, freshly isolated cells were used. 
Cryostat sections of liver, kidney, normal salivary gland 
and the peritoneum were prepared from the same animal as 
the tumour cells. Three sections of each substrate were 
measured for ach animal. The results were calculated as 
for the Bl6 cells.
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2.3. RESULTS
^ ) Comparison of the metastatic potential of B16 FIO and Fl 
cells following intravenous and intraperitoneal 
injection.
1. Intravenous Injection.
A pilot experiment was conducted using B16 FIO cells. 
The number of tumour deposits on the pleural surface of 
both lungs was compared with the number of tumours per 
square mm on histological sections (Fig. 3). The 
correlation coefficient obtained (r2 = 0.78) led to the 
conclusion that counting surface deposits was a 
satisfactory method and this practice was subsequently 
followed.
Twelve days after injection with 2 x 105 B16 FIO cells 
animals were killed and the tumour deposits in the lung 
counted. The mean number of tumours was 212.19  ^ 23.8 
(mean ^ 1 standard error) from 32 animals. These animals 
were further examined at post mortem and no other tumours 
were found. In a comparable experiment with B16 Fl cells a 
mean of 5.0 ± 1.9 (ISE) tumours per animal was found from 
10 animals (Fig. 4). In some animals injected with Fl 
cells an occasional tumour was found in the liver. There 
was a significant difference in the lung colonising 
capacity of Fl and FIO cells (p<0.0001).
Intraperitoneal injection.
Bl6 Fl and FIO cells were injected into the peritoneal 
cavity and the number of deposits on the small intestinal 
mesentery counted after 5 days. With B16 FlO cells a mean 
of 66.5 i 5.1 (ISE) deposits were found in 15 animals. B16 
Fl cells produced a mean of 76.7 ± 11.08 in 15 animals 
(Fig. 5).
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When these means were compared there was found to be no 
significant difference in the ability of these cells to
grow in the peritoneal cavity of the C57 BL6 mouse. There
was no evidence of distant metastasis with either cell 
line.
b) i. Effects of intraperitoneal passage on B16 FIO cells.
The ability of cells to form intra—abdominal tumours 
was assessed following 12 and 18 passages through the 
abdominal cavity. After 12 passages the mean number of
tumours per animal was 69.5 ^ 6.32 (ISE) (N =19). After IB
passages the number of tumours was 103.27 7.78 (ISE)
(N =11). After 18 passages the number of tumours was 
significantly greater (p< 0.0001) than obtained with 
unpassaged cells 66.5 ^ 5.1 (ISE) (N = 15).
Cells derived from the 18th passage were injected 
intravenously and the number of lung lesions compared with 
the unpassaged FIO cells. The average number of tumours 
per animal was 260.07 (N = 17) as compared with 212.19 ± 
23.8 (ISE) (N = 32) for unpassaged B16 FIO cells (Fig. 6). 
This difference was not significant. Animals injected with 
passaged cells were carefully examined and no tumour was 
found in any animal tissue except in the lung,
ii. Effect of repeated intraperitoneal passage on the
behaviour of Bl6 Fl cells.
The ability to form intraperitoneal tumours was 
assessed after 9 and 16 passages. After 9 passages a mean 
of 10.8 3: 1.93 (ISE) tumours per animal was seen (N = 5). 
After 16 passages a mean of 11.13 ± 1.74 (N = 12) tumours 
per animal were found. Cells from both passaged lines 
formed significantly fewer (p< 0.01) abdominal lesions than
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unpassaged Fl cells (76.7 ± 11.08, N =15) (Fig. 7).
Cells from these passages were also tested by IV 
injection. After 9 passages the mean number of tumours 
formed in the lung was 2.0 ± 0.18 (N = 6). This was not 
significantly different from the unpassaged cells (5 ±
1.9. N =10). However after 16 passages the numbers of lung 
lesions greatly increased to 66.89 ± 11.91 (ISE) (N =11). 
This was significantly greater than the unpassaged cells 
(p'^O'OOl) . Tumours were not seen in any organ other 
than the lungs in animals injected with Fl cells passaged 
16 times through the peritoneum.
The intraperitoneal passage of Fl cells proved to be 
rather more difficult than the passage of FIO cells. On 
two occasions cells failed to grow at 6th and 8th passage 
respectively both in vitro and when injected intra­
peritoneally. Continuance of the passage on the third 
occasion was only achieved by increasing the cell 
concentrations after the 6th passage and allowing the 
tumour to grow for more than 2 weeks.
On each of these three occacions unpassaged Fl cells 
were used to begin a new series of passages. Unfortunately, 
no stored cells were available from the first two series of 
passages.
c) Trapping of ^\cr B16 FlO and Fl cells following—
intravenous injection.
i. Retention of ^^Cr in cells in vitro.
The radio-activity remaining In replicate cultures at
varying times after removal of radioactive medium was 
measured. From this data It was estimated that the half 
life of retention was about 12.5 hours (Fig. 8).
70
2. Comparison of lung trapping of Fl and FIO cells.
The radioactivity of the lungs was measured in groups 
of animals killed at 2 and 4 hours after injection of 
radiolabelled cells. At 2 hours the mean radioactivity 
after injection of FIO cells was 3356 ± 352 (N = 18) cpmg"! 
and after injection of Fl cells was 1260 ± 200 (N = 16) 
cpmg-1' This difference is significant at (p<0.0001)
(Fig. 9). At 4 hours much lower levels of radioactivity 
were observed. In the case of FIO cells the mean was 403 ^ 
74 (N =16) cpmg-1 and Fl cells 209 * 34 (N = 7) cpmg-1
(Fig. 10). This again is significantly different 
(p< 0.05).
The trapping in lung of radiolabelled Fl cells was 
compared with radiolabelled Fl cells following the 16th 
intraperitoneal passage (Fl P16). The mean lung 
radioactivity after 2 hours following injection of 16th 
passaged cells was 1511 ± 250 (N = 7) cpmg"^. This is not 
significantly different from the unpassaged Fl cells (1260 
^ 200 cpmg“l)•
d ) The effect of intraperitonal passage on in vitro growth.
The yield of cells after 7 days in culture was
measured for B16 FIO cells, Fl cells, FlO cells derived
from passage 18 (FlO P18) and Fl cells from passage 16
(Fl P16). FIO cells produced (2.38 ± 0.7) x 106 cells/25cm2
flask, Fl cells produced (2.18 ± 0.9) x 106 cells/25cm2 amd
FIO P18 produced (2.24 ± 0.05) x 106 cells/25cm2. There
was no significant difference between these cell lines. On
the other hand the Fl P16 line produced only (0.1 ± 0.01) x
10® cell/25cm2. This was significantly less (p<<>.001) than
any of the other cell lines. This result confirmed the 
great difficulty in propagating passaged Fl cells.
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vA^q.cell adhesion of B16 cells to various organs.
The adhesion ratio for Fl FIO Fl P16 and FIO P18 cells 
were calculated by dividing the adherent cells per on
liver, lung and peritoneum by the number adhering to a 
section of the same tumour. These results are shown in 
table 1 below:
Table 1
Lung Liver Peritoneum
Fl 1.02 ± .3 0.25 ± .03 1.03 ± 0.02
FIO 0.65 ± .1 2.25 ± i.i 1.05 ± 0.5
Fl P16 0.65 ± .1 1.39 ± 0.5 0.25 ± .01
FIO P18 0.39 ± .02 0.16 ± 0.6 0.5 + .17
There is clearly no significant correlation between 
the cell adhesion assessed by this assay and the pattern of 
in vivo growth which w(:v< . observed after intravenous or 
intraperitoneal injection.
Figure 11 shows an examples of one of these 
preparations.
f) Morphological studies of Bl6.
1. Cultured cells.
B16 Fl and FIO and passage cell lines had an 
essential^similar appearance in culture. All cell lines 
grew mainly in the form of spindle shaped cells (Fig. 12).
An exception to this was seen in the 8th and 9th passages 
of the Fl cells. At this stage the cells had a more 
epithelioid appearance and frequent binucleate cells were 
seen (Fig. 13). These changes disappeared in later 
passages the cells reverting to a more spindle shaped 
appearance. At low cell density cells showed
extensive spreading with long cellular processes leading to
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an almost neuronal appearance. A feature of all the cell 
lines in vitro was the release,membrane bound vesicles into 
the medium. These were readily visible wittf^light 
microscope. At higher cell densities both cell lines 
behaved as transformed cells with absence of contact 
inhibition readily apparent.
Passaged cells and their parent cell lines all stained 
positively with Schmorl's method and the vast majority of 
cells showed evidence of melanin synthesis by the DOPA 
staining method (Fig. 14). Many cells were also pigmented 
and release of melanin into the medium was readily apparent 
after a few days in culture.
Cells prepared for injection showed no tendency to 
aggregate.
2. Metastatic lesions.
Pulmonary lesions were identical irrespective of the 
cell of origin. The lesions contained a relatively uniform 
population of large epithelioid type melanocytes often with 
prominent pigmentation. Nuclei were large and moderately 
pleomorphic with prominent nucleoli. Metastatic lesions 
within the lung were frequently angiocentric (Fig. 15) 
although tumour cells were not often seen within blood 
vessels. Tumour deposits on the lung surface were often 
composed of relatively flat plaques of cells apparently 
spreading along the pleural surface (Fig. 16). Tumour 
cells did not invade across the pleural surface and pleural 
adhesions were never seen. The lesions which were produced 
in the abdominal cavity were identical to those seen in the 
lung. Macroscopically two distinctive type of lesion were 
seen. An almost invariaV^ feature of animals injected with
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tumour cells into the peritoneal cavity was the presence of
a large friable mass of tumour in the left hypochondrial 
region related to the spleen and stomach. This was loosely 
attached to the surrounding structures and was readily 
removed for use as the the source of cells in passage 
experiments. Histologically these lesions sometimes showed 
areas of necrosis but blood vessels also were a prominent 
feature presumably resulting from tumour-stimulated 
angio-genesis. The second type of lesion took the form of 
small deposit which were present mainly in the mesentery of 
the small intestine and associated with the intestinal 
serosa (Fig. 17, 18). The lesions were comparable in size 
to those seen in the lung. Although the tumour deposits 
were firmly attached they were not invasive or destructive 
of surrounding structures. Tumour deposits on the parietal 
peritoneum were rare in comparison to those on visceral 
surfaces.
g) Characteristics of Mouse Salivary Tumour.
All the tumours examined were identical in appearance. 
They were multilobed, encapsulated and consisted of regular 
polyhedral cells with relatively little nuclear 
abnormality. Mitoses were frequent, reflecting the rapid 
growth but no abnormal mitotic figures were seen. The 
tumours were sometimes seen to form small acini containing 
PAS positive material particularly at the edge of the 
nodules. A complete fibrous capsule was present and local 
invasion was never seen (Fig. 19). In some cases a 
lymphoplasmacytic infiltrate was present. In over 100 
animals examined no evidence of metastasis was seen.
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The median time when tumours became visible was 16 
weeks after injection of virus. Tumours ultimately 
occurred in 32% of animals (2:1 male : female).
h) Transplantation Experiments using the Mouse Salivary 
Gland Tumour.
When cell suspensions were prepared from these tumours 
and injected subcutaneously or into the peritoneal cavity 
no tumours were seen after one month (N = 10). In this 
period residual tumours in the neck had usually regrown to 
a large size.
When small cubes of tumour were placed in the 
peritoneal cavity many were firmly attached and viable 
after one month but showed little evidence of significant 
growth compared with the rate of regrowth of the primary 
tumour. Histological studies of these lesions showed them 
to be attached to the peritoneum by fibrous tissue and were 
often related to the healed laparotomy scar (Fig. 20).
i) In vitro adhesion of Mouse Salivary Tumour Cells.
Adhesion of polyoma salivary tumour cells is expressed 
as a ratio of cells per mm^ attached to the substrate 
tissue as compared to cells per mm^ attached to a section 
of tumour from the same animal. The results were as 
follows :
Table 2
Kidney 0.72 ± 0.19 N = 8
Liver 0.65 ± 0.15 N = 8
Peritoneum 1*4 0.57 ^ _ n
Salivary Gland 2.4 ± 1*3 N - 9
Using a paired t-test adhesion to liver and kidney was 
significantly less ( p < 0.01) than to autologous tumour. 
However there was no significant difference between tumour, 
salivary gland and peritoneum.
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2.4. DISCUSSION
The B16 FIO and FI cells which were obtained for this 
study were remote from their original source; about 20
years having elapsed since they were derived from a mouse 
tumour. It was therefore essential that the 
characteristics should be verified and compared with their 
original description (Poste and Fidler 1980). Morpho­
logical studies of both the FIO and FI cells clearly showed 
them to be melanocytic in differentiation. The medium used 
in this study (enriched Ham's FIO) differed from that used 
by other investigators. It was chosen and formulated from 
pilot experiments which indicated that it gave clearly 
superior cell growth. The assessment of metastatic 
colonisation of the lung was identical to that used by most 
other investigators (Fidler & Kripke, 1977, Poste & 
Nicolson, 1980). It was compared with a morphometric 
method but in view of the close correlation the latter was 
abandoned because of the effort involved was much greater 
than counting pleural lesions. The number of lung tumours 
produced by the two cell lines was similar to that 
described by others although the FI cells were perhaps 
rather less metastatic. Lesions outwith the lungs were 
occasionally found after injection of Fl cells but never
with FIO cells.
It has previously been suggested that the difference
in lung homing potential of the Fl and FIO cells may be due
to the initial pulmonary trapping following intravenous 
injection (Fidler, 1975). This experiment was repeated 
using 51cr instead of 125x-iododeoxuridine.Chromium 
labelling is a much simpler procedure but has the
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disadvantage that thæ label is gradually lost, being
released from cells by passive exocytosis. However 
chromium has been used successfully for this type of 
experiment by other investigators (Suemasa and Ishikara, 
1970) Fl and FIO cells showed no difference in labelling 
characteristics and the rate of loss of label as determined 
over 24 hours suggested that the loss would not materially 
affect trapping measurements made within four hours. It 
was found that FIO cells were more avidly trapped in the 
lung than Fl cells both at 2 hours and 4 hours after 
intravenous injection. However the overall radioactivity 
was much less at 4 hours for both types of cells. Part of 
this loss may be due to the loss of label from trapped 
cells but from the data presented this probably does not 
account for the whole of the reduction. The residue is 
likely to represent cell loss from the lung either by 
passing through the capillary bed or by traumatic lysis.
The latter phenomenon has been described in other systems 
(Sato & Suzuki, 1976). It is concluded that only a 
relatively small proportion of the cells which initially 
lodge in the pulmonary capillary bed are likely to emigrate 
into the parenchyma and form nodules of tumour. In this 
respect the B16 cell lines used in the present study
resemble those described elsewhere.
When injected intravenously the FIO cell line is 
highly specific for lung whereas the Fl cell line has a 
much lower tendency to grow there. In preliminary 
experiments it was found that both cell lines would grow 
readily in a variety of sites when Injected directly; the 
peritoneal cavity, pleural cavity and subcutaneous tissues
77
were tested. It was therefore decided to attempt to 
compare these two cell lines quantitatively with respect to 
local growth. Such comparison has not been previously 
reported. The peritoneal cavity was thought to have a 
number of advantages for making this comparison. Firstly 
cells would be free in suspension and in order to grow 
they would require to attach to a surface. Thus, tumour 
deposits formed in the peritoneal cavity could be assumed 
to be formed from single cells and in this respect would 
be more comparable with the results of intravenous 
injection. It should be noted that cells injected 
intraperitoneally or intravenously were single cell 
suspensions, with no evidence of cell aggregates as far as 
could be determined by light microscopy. Direct injection 
into a solid organ such as liver or skin would have 
resulted in a compact mass of cells and no indication would 
have been given as to the number of initial cells actually 
capable of growth. Secondly, the small intestinal 
mesentery was a readily identifiable structure in which to 
count the number of deposits. When Fl and FIO cells were 
compared in this way no difference was found in the 
formation of metastatic deposits in the small intestinal 
mesentery. The finding that the Fl and FIG cells were 
equally tumourogenic following direct injection into the 
peritoneal cavity is consistent with the results of 
trapping studies which suggest that the difference in lung 
homing behaviour of these cell lines may be at the level of 
interaction with the pulmonary vascular bed. However, 
since it was not possible to test tumour forming ability 
after direct intrapulmonary injection it must remain
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possible that the environment of the lung could result in 
the growth differences between the cell lines.
Nevertheless, both Fl and FIO are able to grow at a number 
of sites (skin, peritoneum, pleura) where metastasis are 
never seen after IV injection which again suggests that the 
site specificity at least in part may be a function of cell 
interaction with the vascular system. The ability of FIO 
cells to form deposits in subcutaneous pulmonary grafts 
(Hart & Fidler, 1980) and relative lung specificity after 
intra-arterial injection (Weiss et al, 1984) suggest that 
at least some cells capable to forming tumours survive as 
least one passage th^ 'c^ sgh a capillary bed.
The explanation given for the lung specificity of the 
B16 FIO cell line is that it is a result of a selection of 
lung homing cells from an initially heterogeneous 
population by repeated passage. In view of the results 
obtained by intraperitoneal injection^it is relevant to ask 
whether repeated passage of cells from mesenteric FIO 
tumours following direct injection will result in a cell 
line with increased tumour forming ability at this site, 
and if such a line can be derived, whether it will form 
tumours in the peritoneum when injected intravenously.
When FIO cells are repeatedly passaged through the 
peritoneal cavity it was found that the number of 
mesenteric tumours following IP injection increased 
significantly by about 50% at passage number 18. However, 
the number of lung tumours which resulted from IV injection 
of these cells was not significantly different from the 
unpassaged cells, and no tumours were seen outwith the 
lungs.
79
These results show that the cell line produced by 
repeated intraperitoneal passage (FIO P18) has an increased 
ability to form tumours in the peritoneal cavity after 
direct injection, but has retained the parent cell lines 
tumour forming properties after IV injection. This 
excludes the possibility that the mesenteric deposits are a 
result of a discrete subpopulation of cells distinct from 
those which form lung tumours. However it suggests that 
the two properties are independent. Increase in mesenteric 
tumour formation, without change in lung tumour forming 
ability, could have resulted from selection of a population 
with enhanced mesenteric tumour forming ability from a 
larger population with constant lung colonising potential. 
Alternatively, the increase in mesenteric tumour formation 
may have been induced by the environment of the peritoneal 
cavity. The possibility of induction of lung homing was 
tested using FIO cells encapsulated in microspheres, thus 
eliminating specific lung trapping (Nicolson & Ousted,
1982). No such effect was found. Nevertheless, this does 
not exclude the possibility of an inductive effect causing 
increased mesenteric tumours after direct injection. 
Avoidance of the circulation may have been expected to 
increase the efficiency of the process of tumour formation 
but even after IP injection less than 1:1000 cells appear 
to give rise to tumours. This observed inefficiency is 
consistent with the dynamic heterogeneity model which 
postulates that tumour forming variants are generated at a 
low rate from non-tumour forming cells (Hill et al, 1984). 
The increased generation of these variants by repeated 
passage could be due to either selection or induction.
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A selective mechanism would be possible if colonies of 
tumour cells at a particular site showed a slightly greater 
tendency to generate variants capable of forming tumours at 
that site. This could account for stepwise evolution of 
population with increased tumour forming potential.
Repeated intraperitoneal passage had a much more 
profound effect on the Fl cells. Two distinct phases can 
be discerned. After 8 - 9  passages the resulting cells 
showed distinct morphological changes, becoming more 
epithelioid in character and more often multinucleate.
This was associated with a very marked decrease in the 
ability of these cells to form tumours either after 
intraperitoneal or intravenous injection. Indeed on two 
occasions the passage was terminated at this stage. 
Continuation beyond this stage was only possible in a third 
experiment by increasing the number of cells injected in 
later passages. At the 8th and 9th passage it was almost 
impossible to propagate these cells in vitro.
During the later passages of the third series the 
cells once more began to resemble the unpassaged Fl cells 
morphologically. Cell growth and growth in the mesentery 
following intra-peritoneal injection remained significantly 
less than the unpassaged cells. However surprisingly the 
lung tumour forming ability of the passaged cells increased 
to a relatively high level (about 30% of that seen in the 
FIG cells). This increase in lung tumour formation could 
not be correlated with any increase in the trapping of 
radio-labelled cells. As described above the trapping of Fl 
cells was almost half Uust of FIO cells although the ratio
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of tumours was about 1:20. Therefore it is apparent that 
lung trapping is not the sole limiting factor which
determines the rate of lung metastasis of Fl cells. It
would appear that Fl P16 cells had acquired an increased
capacity for growth at the same level of trapping.
The effect of intraperitoneal passage on the Fl cells 
was unexpected and clearly contrasts with the effect on the 
FIG cells. The initial inhibition of growth and tumour 
forming ability would be most compatible with an inductive 
effect of the peritoneal cavity. As the unpassaged Fl cell 
line contained a large number of cells able to form
mesenteric tumours, it is difficult to envisage how these
could be removed by selection. Moreover, it is difficult 
to see how an in vivo selective pressure could result in a 
population of cell which grow poorly in vitro. The 
emergence of a cell line with a relatively high lung 
colonising ability is also difficult to explain. One 
possibility is that because of poor in vitro growth the
later passages were oligoclonal in culture. This could 
have led to instability in lung colonising ability as has 
been previously described (Poste et al, 1981). Therefore 
the increased lung colonising ability of the F1P16 cells 
could be an indirect consequence rather than a direct 
result of intraperitoneal passage.
The intravenous injection of cells which have been 
repeatedly passaged in the peritoneal cavity did not result 
in tumours in the peritoneum (or any other organ other than 
the lungs). It could be argued from this result that 
intravenous passage and contact with the vasculature is 
essential for the selection of site specific variants such
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as the FIO line. However as the results described above 
show this is not the sole possible mechanism: lung growing 
Fl cells arose without prior contact with the lungs (since 
the derivation of the cell line).
The above discussion has centred on the B16 melanoma 
cell line which was derived from a malignant tumour. 
However it is relevant at this point to consider the 
situation in a benign tumour. The polyoma induced tumour 
used in these experiments never metastasises and has the 
morphological characteristics of a benign tumour. The 
reason for the benign behaviour of this tumour could be 
failure to complete any of the complex steps in the 
metastatic process which are described above in Chapter 1. 
Alternatively, the cells may be incapable of growth in vivo 
at any site other than the salivary gland. To test the 
latter possibility, cells at very high concentration were 
injected directly into the peritoneal cavity. Despite the 
fact that the primary tumours were rapidly growing no 
growth was observed in the peritoneal cavity even after one 
month. This was also the case for subcutaneous 
injections. However, when small fragments of tumour were 
transplanted into the peritoneal cavity these remained 
viable, often attaching to the laparotomy scar but without 
visible growth. These experiments were performed as 
autografts and frequently the primary tumour had regrown to 
a large size during the experiment. These experiments lend 
further credence to the idea that even after direct 
injection some tissue environments do not permit the growth 
of some types of tumour cell. It is possible that the 
failure of cells in suspension to grow was to damage
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during isolation. It is difficult to formally exclude this
possibility, but the methods used are widely employed in 
this type of application and the number of cells used was 
very high, making it likely that some competent cells would 
be present. Therefore it is reasonable to assume this to 
be an unlikely explanation.
A problem with the polyoma salivary tumour which 
prevented further exploitation of this model is that the 
animals used were not inbred so experiments had to be 
performed as autografts. Pilot experiments with various 
inbred strains produced poor yield of tumour. This problem 
was further compounded by the failure of attempts to grow 
the tumour in vitro.
It was hoped that the in vitro adhesiveness of tumour 
cells to various tissues would provide a simple screening 
method of predicting the behaviour of cells in vivo. The 
method of studying attachment of cells to cryostat sections 
was first used to show a specific adhesion of lymphoid 
cells to post-capillary venular endothelium (Woodruff et 
al, 1977). The rationale for using this method is the 
assumption that the type of cell interaction involved in 
metastasis is likely to be mediated through the cell 
surface and that this may be detected by changes in cell 
adhesion. The preservation of cell surface molecules is 
readily apparent in many immunocytochemical applications.
A problem with this method is the limited area of
membrane presented by the sectioned cells. Apparent 
specificity of FIO cells for lung in this type of assay has 
already been reported (Wetland & Zetter, 1984). In the 
present study there was no correlation between lung
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adhesion and the number of lung tumours formed after IV 
injection. As the method followed was essentially similar 
it is difficult to account for this difference. It may 
have been expected that adhesion in this type of assay 
would have correlated more directly with local growth after 
direct injection. The Fl and FIO cells adhered equally 
well to the peritoneal cavity and the Fl P16 were less 
adherent. However FIO P18 which grew best at this site 
were also less adherent, not differing significantly from 
the Fl P16 line. The failure of this assay to be 
predictive of in vivo behaviour is also found with the 
polyoma salivary tumour. Adhesion of these cells to the 
peritoneal cavity where the cells did not grow was not 
significantly different from this adhesion to the tumour 
itself.
The results of these experiments were much more 
complex than had been anticipated. However two distinct 
mechanisms were seen as important in determining the 
growth of metastasising cells. The first mechanisms is 
specificity of trapping at a particular site. This is 
exemplified by the difference in the Fl and FIO cell 
lines. The second is the effect of particular sites on 
tumour cells. This is shown by the total inhibition of 
growth of the polyoma cell by the cells of the peritoneal 
cavity and by the different ways in which the peritoneal 
cavity modified the behaviour of the Fl and FIG lines of
the B16 melanoma.
The next chapter in this thesis will consider the role
which the histocompatability system could play in mediating 
this type of cell interaction.
CHAPTER THREE
The role of histocompatability antigens in mediating the 
cell interactions involved in the growth of metastatic 
tumour cells.
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CHAPTER 3
3.1, introduction
The study of the cell surface proteins collectively 
known as the histocompatibility antigens has its origin in 
the study of graft rejection. One group of genes was found 
to be related to rapid rejection and was termed the major 
histocompatability locus (MHC). However, it was soon 
realised that a large number of other genes could mediate 
less rapid rejection and these are known as the minor 
histocompatability loci. Although the mouse and human 
systems are best characterised there is evidence for 
polymorphic cell recognition systems in virtually all 
metazoan species. For example such a system prevents 
incompatible sponges being grafted (Hildemann et al,
1979). The mouse major histo-compatability complex (H-2) 
is found on chromosome 17 and the structure of this region 
is now known in detail (Steinmetz & Hood, 1983, Klein,
1979). The H-2 complex contains genes of three distinct 
classes; the class I genes K, D and L are located at either 
end of the complex, the class II genes are a group of four 
separate genes; A alpha, A beta, E alpha and E beta and 
finally the class III genes which code for complement 
components. Adjacent to the H-2 complex is the TLa complex 
which contains about 15 minor histocompatability genes as 
well as a number of non-functional pseudo-genes with class 
I homology (Winoto et al, 1983) (see Appendix •
Functional and non-functional genes can be identified using 
transfection into L cells and measurements of class I 
expression by detection and quantitation of surface p2 
microglobulin ( p2 micro- globulin i6 the invariant 
component of all Class I genes).
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Although there is a concentration of histocompatability 
genes on chromosome 17 class I genes are found on all mouse
chromosomes.
The structure of the class I and class II genes and 
their protein products is well characterised. Class I 
genes have 8 exons which code for a leader sequence (1), 
three external domains (2-4)^ a transmembrane sequence (5) 
and a cytoplasmic domain (6-8) (Steinmetz & Hood, 1983 and 
(Steinmetz et al, 1981a). When incorporated into the 
membrane, class I molecules are associated with p2-micro- 
globulin. There is some evidence that alternative mRNA 
splicing of some class I gene transcripts could produce 
different cytoplasmic domains (Steinmetz et al, 1981b).
The class II molecules (I-A and I-E) consists of alpha and 
beta chains both of which bear some similarity to class I 
molecules. A similarity of Class II molecules to the 
T-cell receptor, immunoglobulin and Thy 1 and Lyt 2 
lymphocyte differentiation molecules has been noted and it 
has been postulated that evolutionary relationships exist 
between these molecules (Hood et al, 1985).
The role of the H—2 locus in the mediation of cellular 
interactions has been studied in most detail in the immune 
system. This stems from the work of Zinkernagel & Doherty 
who found that cytotoxic T-cell activity against virus 
infected cells was only effective if both T cells and 
target cell shared the same H-2 class I antigens 
(Zinkernagel & Doherty, 1979). As is now well known this 
work was extended to show that antigen presentation by the 
mononuclear phagocyte system to T cells was restricted by 
the class II H-2 antigens. These observations are of
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fundamental importantance in immunology but they have a 
wider significance in that they show that the function of 
histocompatibility antigens can be studied in at least some 
cases by the demonstration of strain specific restriction 
effects.
The detailed knowledge of histocompatibility antigen 
genetics and structure contrasts with the paucity of 
information as to how cells recognise these proteins. The 
identification of the T cell antigen receptor alpha, beta 
and gamma chains may have been expected to illuminate this 
question but as yet there is no consensus as to the role 
which the T cell antigen receptor plays in major histo­
compatibility locus recognition (Robertson, 1985). It is 
unclear whether recognition of H-2 proteins is mediated 
through the T-cell receptor or whether other surface 
molecules are required in particular the CD4 and CD8 
differentiation antigen (Golding et al, 1985). Nothing is 
known about the recognition of non H-2 histocompatability
ant igens.
Cell interactions, other than those involving the 
immune system have been studied in little detail. When 
primary cultures of renal tubular epithelia derived from 
different strains of mouse are admixed it can be shown that 
contact inhibition of movement is strain restricted 
probably by either the K or D class I molecules (Curtis and 
Rooney, 1979). In this case contact inhibition was 
increased between allogeneic cells. The role of H 2 in 
modulating in vitro cell adhesion has also been studied 
(Bartlett & Edidin, 1978) using a collecting type assay.
When cells of the same H-2 type were mixed variation in
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degree of adhesiveness was found to be a function of H-2 
polymorphisms. Secondly, adhesion was strongly inhibited 
by the presence of anti-H-2 antibodies. Thirdly, a 
significant difference was found between the adhesion of 
cells derived from hybrid animals to each other and 
adhesion to one of the parental types. Histocompatibility 
antigens were also found to be important in the adhesion of 
liver and bone marrow cells (Zeleny et al, 1978). In vitro 
studies of lymphocyte behaviour have shown that B-cell 
adhesion was inhibited by a thymocyte derived factor 
(Curtis & deSousa, 1973). Later it was found that when 
minute amounts of this factor were injected intravenously a 
rapid B-lymphocytosis occurred (Daviis & Curtis, 1981). 
Purification of this factor by affinity chromotography 
showed that it was identical to part of the class I MHC 
molecule H-2D (Curtis & Davif^ , 1981). However, little is 
known about the conditions which lead to the release of 
this molecule in vivo.
These studies strongly suggest that histocompatibility 
antigens are involved in cellular processes other than the 
immune response. Indeed it has been demonstrated that H-2 
molecules can be detected by odour and can affect mating 
preferences of mice (Beauchamp et al, 1985).
-Studies of histocompatability antigen expression by 
tumour cells have tended to focus on the hypothesis of 
immune surveillance and tumour immunity rather than on the 
nature of cellular interactions. In this chapter the 
expression and function of histocompatability antigens will 
be examined in the Bl6 melanoma model with particular 
reference to metastatic potential and growth in distant
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sites. The question will be approached in two ways.
Firstly the highly metastatic lung homing B16 FIO cell line 
will be compared with the poorly metastatic non-lung 
specific B16 Fl cell line with respect to both H-2 class I 
and class II MHC expression. Secondly the effect 
of increased expression of these molecules, induced by 
retinoic acid, will be studied in vivo. Thirdly the 
ability of the highly metastatic FIO cell line to grow in 
animals of various genotypes will be studied in an effort 
to demonstrate strain-related restriction effects similar 
to those discussed above.
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MATERIALS AND METHODS
The general methods of cell culture and the conduct of 
animal experiments were identical to those described in 
Chapter 2. The same methods were also used to assess lung 
and peritoneal metastasis and cell trapping by the lungs.
^ Qf mouse genotype on metastasis formation.
To test the effects of varying the genotype of the 
recipient animal on the growth of injected cells the 
following experiments were performed. Two groups of 
animals were initially used. Group A consisted of C57 BL6 
mice (the syngeneic strain for the B16 melanoma) and Group 
B consisted of Fl hybrids which resulted from the mating of 
C57 BL6 with balb c. These animals were each injected with 
2 X 105 B16 FIO cells as described previously. The cells 
used were derived from the same culture flasks. The number 
of tumour deposits in the lungs of these animals was 
compared using Student's t-test. These experiments were 
then repeated using Fl hybrid animals which were produced 
by C57 BL6 x balb b mating (H-2b homozygous). ^  ee Appendix 
4 .
Comparison of the number of peritoneal deposits 
resulting from the intraperitoneal injection of 2 x 105 FIO 
cells was also made using the C57 BL6 and Fl hybrid 
animals.
Syngeneic and C57 BL6 x balb c animals were compared 
with respect to the trapping of radioactively labelled B16 
FIO cells in the lungs. The mean radioactivity in each 
group of animals was compared using Student’s t-test.
b) Comparison of H-2 expression on Fl and FIO cells.
The expression of H-2 class I (KbDb) and I-Ab antigens
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expression were assessed by immunofluorescent staining. Two 
mouse monoclonal antibodies were used for this purpose. 
Clone 5041 - 16.3 recognises a shared déterminent on both 
the K and D products of the b haplotype. The MRC OX-3 
monoclonal antibody recognises the I—A b haplotype product 
as well as the la product of some rat strains. Both 
antibodies were supplied as ascites fluid by Serotec 
Limited.
Four to six million B16 FIO or Fl cells were prepared 
as above, harvested, pooled and washed in MEM and then 
resuspended in 0.2 ml of calcium and magnesium free 
Dulbecco's phosphate buffered saline. This suspension was 
divided into two aliquots each of 0.1 ml and to one of 
these was added 15pl of undiluted antiserum. These 
suspensions were left on ice for 20 minutes. The cells 
were then pelleted by centrifugation and washed twice in 
Dulbecco's PBS containing 0.05% sodium azide and 0.1% 
bovine serum albumin. They were then resuspended in 0.1 ml 
PBS to which 20pl of rabbit anti-mouse immunoglobulin - 
FITC conjugate (Dako Ltd) was added. This was incubated on 
ice for a further 30 minutes and the cells were then washed 
three times in PBS containing0 'Of% sodium azide and 
resuspended to about 106 cells per ml in phosphate 
buffered saline. A small aliquot was placed on a glass 
slide and examined under ultraviolet light,
c ) Quantification of Fluorescence Intensity.
In these experiments only cells stained and measured 
at the same time were compared.
The cell suspensions prepared as above were analysed 
using the fluorescence activated cell sorter (FACS II,
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Becton Dickinson) which employs a 500mW Argon laser for 
maximum fluorescence activation and photomultiplier at 
450V. About 10^ cells from each sample were counted and 
measured. Cells which had not been treated with specific 
antibodies served as a measure of autofluorescence and 
non-specific binding of the rabbit anti-mouse - FITC.
(Fig.21-22).
The FACS II recognises 256 channel steps in 
fluorescence intensity. The number of cells counted in 
each channel were used to calculate the number of cells at 
thirteen levels of intensity. This is analogous to varying 
the gain of the photomultiplier and making separate 
counts . The method of Fathman et al (1975) was used to 
subtract autofluorescence from each of these measurements 
so as to obtain a measure of the number of specifically 
fluorescent cells.
If E is the proportion of total cells detected at a 
particular level of fluorescence intensity then this will 
include the proportion which stain non-specifically at 
this level and to (3 the proportion of the total which stain 
specifically.However since autofluorescence and specific 
staining are independent then P will be the proportion in 
cells of both categories:
thus E = '«aC + P - ck.P 
3 “ E- o<
1 -
E is measured from the specifically stained sample and 
from the autofluorescence control. Therefore, 3 the 
proportion of cell specifically stained and hence the 
absolute number can be calculated.
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TO compare Fl and FIO cells Chi squared tests were
performed using a fourfold table. The total number of
positively stained cells with each antibody were compared 
as well as those stained with high intensity defined as
fluorescence intensity greater than that detected by 
Channel 121.
To examine the possibility that differences in 
fluorescent intensity were related to cell size, plots of 
intensity versus cell size were obtained using the FACS II 
system.
d ) Induction of cells with retinoic acid.
The aim of these experiments was to examine the
possibility that retinoic acid would induce MHC expression 
and so alter the in vivo metastatic potential of the 
cells .
Fl and FIO cells were plated as before. After 3 days 
retinoic acid was added and the cells used 5 days later, 
Retinoic acid stock solutions were prepared from 
crystalline retinoic acid (Sigma) dissolved in 95% ethanol: 
5% water v/v.
The effects of retinoic acid on growth were assessed 
as follows. Replicate 25cm2 cultures were prepared and 
varying concentrations (lOrG to 10- 10m ) of retinoic acid 
added. After 5 days cells were removed and counted. The 
results were expressed as cells per 25cm2 flask for each 
concentration of retinoic acid and mean and standard error 
were calculated. These were compared with untreated 
controls using a t-test.
The expression of H-2 (K and D) and T—A were assessed
as described above using cells which had been treated for 5
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days with either 10-6m or 10-9» concentrations of retinoic 
acid. The results were then analysed following the methods 
described above. Again only cells stained and measured on 
the same day were compared.
To test the effects of retinoic acid on in vivo growth 
groups of C57 BL6 mice were injected intraperitoneally and 
intravenously with FIO and Fl cells induced with 10“6 and 
1Q-9m retinoic acid. The number of tumours were assessed 
as described above.
The trapping of cells in the lung was studied using 
radiolabelled cells induced with 10-6 and 10-9M retinoic 
acid and compared with uninduced cells.
e) Assay for natural killer cell activity. (Appendix 5).
In these experiments B16 FIO cells were used as 
targets. These were radiolabelled as described previously 
with 51cr. 5 % lO'^  cells in 50pl of media were added to
each well of a microtitre plate.
Effector cells were prepared from the spleens of C57 
BL6 (N = 6) and C57 BL6 x balb c (N = 6) Fl hybrid 
animals. The spleens were removed and cut into three 
pieces. They were then gently squeezed to remove lymphoid 
cells which were suspended in Ham's Fl0 medium containing 
10% foetal calf serum. These cells were then incubated at 
37*C for one hour to remove plastic adherent cells. The 
cells remaining in suspension were then counted and 
resuspended.
Spleen cells prepared in this way were then added to 
wells containing the radiolabelled Bl6 melanoma cells.
Each well received either 5 x I06 or 1.6 x 10  ^ spleen cells 
in 150 pi of standard medium. As controls B16 cells were
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incubated either with 150 jal of medium or with 150 pi of 
phosphate buffered saline containing 10% Nonindet P-40 
(Sigma).
After two hours 100 pi of medium was removed from each 
microtitre well and counted in a gamma counter. The 
radio-activity from cells which had been treated with 
detergent was taken as the maximum possible release. The 
radioactivity from cells treated with medium alone was 
taken as the spontaneous release. These values were then 
used to calculate the cytotoxic effect of the spleen 
cells. The cytotoxicity of the syngeneic and Fl hybrid 
spleen cells was compared.
96
3.3. RESULTS
a ) Expression of major histocompatability antigens by FI 
and FIQ cells.
1. Immunofluorescence Microscopy
It was apparent on ultraviolet microscopy that there 
was considerable heterogeneity of staining of tumour 
cells. Many cells were unstained by either antibody. 
Positive staining varied from a few tiny dots on the cell 
surface to near continuous membrane staining. This was 
similar with both antisera used. In control suspensions, 
where the primary antisera had been omitted, no bright 
green fluorescence was ever observed although a dull green 
autofluorescence was sometimes seen in the cell cytoplasm.
2. Fluorescence activated cell sorter analysis.
i. Staining with anti-H-2b, k and D (clone 5041 - 16.3 
monoclonal antibody). (Figs. 21 and 22).
The number of positively staining cells was calculated 
as described above. With this antibody 7535 of 8661 ( 87%) 
of FIG cells were positively stained after subtraction of 
autofluorescence. Cultures of FI cells stained and 
measured under identical conditions showed positive 
staining in 4937 of 9831 cells (53%). Testing the null 
hyposthesis that there is no difference between these 
populations, Chi squared = 245.4; p^ 0.0001.
When only brightly stained cells are considered 
(intensity greater than channel 121) 2685 from 8611 (31%) 
of FIO cells were positive as compared to 1735 of 7596 
(23%) of FI cells. Chi squared in this case is 373.12 p<
0.0001. Thus there is a highly significant difference in 
the number of cells of each type staining with this
antibody.
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i i• Staining with anti-I-A^ (monoclonal antibody MRC-0X3).
Using this antibody 6489 of 9271 (67%) of FIO cells 
showed positive staining as opposed to 4350 of 9802 (44%) 
of Fl cells measured. Chi squared in this case was 281.25; 
p <0.001. When high intensity staining alone was 
considered 649 of 9271 (7%) of FIO cells were stained 
compared with 252 of 9550 (3%) of Fl cells, Chi squared = 
201 p Of.OOl.
These results show that significantly more FIO cells 
express H-2 KD and 1-A than Fl cells. However it is 
noticable that many fewer cells express the I-A determinant 
than the class I proteins and that very few cells expressed 
I-A with high intensity.
This experiment has been repeated subsequently on 
several occasions with qualitatively similar results. There 
was no apparent relationship between cell size and 
fluorescence intensity (Fig. 23-25).
b ) Induction of B16 cells with retinoic acid.
i. Cell growth.
Cells incubated for 5 days in concentrations of 
retinoic acid from 10-6 to lO-l^M show variable dose- 
related inhibition of growth. At 10“6m the final cell 
density was almost one third of the control value. Using a 
t-test this was significant at p<0.01. Cells grown at 10 7 
and 10“6m retinoic acid also showed significant inhibition 
of growth p< 0.05. There was no significant inhibition at 
10-9 or 10-10% retinoic acid (Fig. 26).
ii. Cell morphology.
No apparent difference in the appearance of either Fl 
or FIO cells could be detected after treatment with
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retinoic acid. A rather inconstant finding was the 
presence of excess melanin pigment in the medium; most 
cultures treated with IO'^m retinoic acid showing marked 
discoloration after 3 - 4  days.
c ) Effect of retinoic acid on expression of H-2 KD and I-A 
determinants.
i. Cells treated with 10~6m retinoic acid.
After induction with 10"^M retinoic acid an increase 
of 38% in the number of Fl cells staining with the anti-H-2 
K,D antiserum was found. 18% more cells showed high 
intensity fluorescence (Fig. 27). Using the anti-I-A 
antibody 22% more retinoic acid treated cells were stained 
that the uninduced controls (Fig. 28). A 3% increase was 
found at high intensity (Fig. 28).
In each case the difference between induced and 
non-induced cells is significant (p<0.001) using Chi 
squared
A similar pattern was seen with FIO cells treated with 
this concentration of retinoic acid. An 8% increase in the 
number of cells stained wiCh the antibody to class I 
determinants and a 4% increase in cells staining at high 
intenity was found (Fig. 29). Using the anti-I-A antibody 
8% more induced cells were stained than uninduced cells.
At high intensity the increase was 2% (Fig. 30).
The increase in the number of cells stained with each 
antibody after induction was significant (pfO.OOOl) using 
Chi squared bCSt-.
ii. Cells treated with 10-9% Retinoic Acid.
using retinoic acid at lO'^M there was no change in 
the number of Fl cells staining with anti-H-2K,D. A 3%
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^^crease in the number of cells stained with anti-T-A was
found. This was not statistically significant (Fig. 31). 
ot FlO c-tVU
Induction^with 10-9M retinoic acid produced a 3% 
increase in staining with anti—H—2 (KD) which was not 
significant (Fig. 32) . However the number of cells stained 
with anti-I-A increased by 18% which was significant at p<
0.001 using Chi squared .
d) The effect of retinoic acid induction on the tumour
forming capacity of FIO and Fl cells.
1. Intravenous Injection.
B16 and Fl cells were induced for 5 days as described 
above with 10-6% and 10-9% retinoic acid. Following 
intravenous injection of both Fl and FIO cells induced with 
10-6% retinoic acid no tumour deposits were found in the 
lungs of 10 animals injected with each cell line. With FIO 
cells induced with 10-9% retinoic acid a mean of 16.7 ^ 5.8 
(n = 10) tumours per animal were found (Fig. 33). When 
compared with uninduced FlO cells this was a significant 
decrease (Student's t-test p < 0.0001). When this experiment 
was repeated using Fl cells at 10-9% retinoic acid a mean 
of 1,5 i 0.5 (n = 10) tumours per animal was found. This 
was not significantly different from the uninduced Fl cells 
Fig. 34).
The lungs of animals showing no tumour were carefully 
examined histologically to exclude the possibility that 
failure to observe tumour on the pleural surface was due to 
a reduced rate of growth. However, there was no evidence 
of tumour in any of these animals,
ii. Intraperitoneal injection.
Retinoic acid treated FlO and Fl cells were used in
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the same protocol as described above. Again when 10-6% 
retinoic acid was used no tumours were seen in the 
peritoneal cavity with either cell line. When FIO cells 
were induced with lQ-9% retinoic acid a mean of 21 ± 4.5 (n 
= 10) tumours per animal was found. This is a significant 
reduction compared to the uninduced FlO cells at P<0.001 
(Fig.35). When 10~9% retinoic acid Fl cells were used a 
significant decrease in the number of tumours (44.9 ± 8.5 
(n = 10)) was also observed P<0.05 (Fig. 36).
iii. The effect of retinoic acid induction in the trapping 
of B16 Fl and FlO in the.. lungs.
Cells which had been induced with retinoic acid were 
used in the same assay as previously described. B 16 FIO 
cells induced with 10-6% retinoic acid gave a mean lung 
radioactivity of 1149 ^ 107 cpm/g (N =12) at 2 hours. This 
was a significant reduction (p < 0.001) as compared to 
untreated cells at Q. ( 3350cpm/g ) . Fl cells induced by 
10-6% retinoic acid showed a marked rise in lung 
radioactivity with a mean of 3984 ^ 590 (N = 10). This was 
significantly greater (p< 0.001) than in the control
animals (Figs.37-38).
Labelled B16 Fl cells treated with 10-9% retinoic acid
gives a mean lung radioactivity of 1413 ^ 248 (cpm/g) (10 = 
N). This is not significantly different from the uninduced 
Fl cells. When labelled FIO cells induced with 10-9% 
retinoic acid were used a mean lung radioactivity of 2478  ^
416 cpm/g was found. This was not significantly different
from the uninduced FlO cells (Figs. 37,38).
In summary Fl cells induced with 10'6m retinoic acid
showed greatly increased trapping. The levels were
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comparable to that seen with uninduced FIO cells. However 
induction of FIO cells at this concentration resulted in a 
decrease in lung trapping. At 10-9% retinoic acid both 
cell lines showed similar levels of lung trapping as the 
uninduced cells.
e ) The effect of recipient genotype on the metastatic 
potential of FlO cells,
i. Intravenous injection.
Injection of 2 x 10  ^ B16 FIO cells intravenously give 
a mean number of lung colonies of 212 ± 23 in the syngeneic 
C57 BL6 mouse. In the C57 BL6 x balb c hybrid animal the 
corresponding number of lesions was 20.5 ± 4 (n = 21).
This is significantly less than in the syngeneic animals at 
(p< 0.0001). The experiment was repeated using C57 BL6 x 
balb b (H-2b homozygous) hybrids and the mean number of 
lesions found was 23.2 ± 7.2. This did not differ 
significantly from the C57 BL6 x balb c hybrids. Tumours 
were not seen in any other organ other than the lung (Fig.
39).
ii) Intraperitoneal injection.
The number of tumour deposits in the small intestinal 
mesentery was compared in the C57 BL6 and C57 BL6 x balb c 
hybrids. The C57 BL6 showed a mean number of tumours of 
66.5 ± 5.1 (N = 15) and the hybrid animals a mean of 63 + 
5.8 (N = 15). This difference was not significant (Fig.
40).
iii) Trapping of radiolabelled FlO cells in syngeneic and_ 
Fl hybrid animals.
Radiolabelled FIO cells were injected intravenously 
into C57 BL6 x balb c hybrids and the retained lung radio-
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activity compared at two hours and four hours. The mean 
lung radioactivity at two hours in the hybrid animals was 
4090 ± 341 cpm/g (N = 18) as compared to 3356 ± 352 cpm/g 
(N = 18) in the syngeneic animals. Although the mean
obtained in the hybrid animals was rather higher the
difference was not significant (Fig. 41).
At 4 hours the results were similar. The C57 B16 x
balb c hybrid had a lung radioactivity of 616 ± 6 4  (N = 19)
as compared to the C57 BL6 control animals which showed a
mean of 463 ± 74 cpm/g. This again is not a statistically
significant difference (Fig. 42).
f) Detection of anti-Bl6 FlO natural killer cell activity.
Using B16 FIO cells as targets, spleen cells from 
C57 BL6 and C57 BL6 x balb c hybrids were tested for
natural killer cell activity. In neither case was there
any evidence of significant NK cell mediated lysis of the 
B16 cells.
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discussion
It is apparent from the immunofluorescence data that a 
significantly greater proportion of B16 FIO cells stained 
positively with both the anti-KD and the anti-I-A 
antibodies than the B16 Fl cells. The antibodies used in
this study were obained from a commercial source. In both
cases the antigenic specificity of the monoclonal 
antibodies had been determined by cytotoxicity analysis of 
cells from recombinant mouse strains (manfacturers data). 
MRC-0X3 has also been used in immunoprécipitation studies 
of T-A antigens (McMaster and Williams, 1979). As the 
characterisation of these antibodies was carried out using 
spleen cells, it remains a possibility that they could 
recognise a cross-reacting determinant on the B16 melanoma 
cells. It was hoped to exclude this by performing
"Western" blot analysis of separated B16 proteins.
However, unfortunately neither antibody performed well in 
this analysis, even at high concentrations. Therefore, in 
the following discussion the not unreasonable assumption 
is made that the antibody specificity in B16 melanoma is 
the same as has been described in spleen cells. The data 
illustrated in figures 21-32 are representative of a series 
of experiments conducted using the B16 cell lines stained 
with these antibodies. As these results were obtained at 
different times it is not possible to pool the data.
However in each case the results were qualitatively 
s imilar.
The expression of class I MHC molecules on tumours is 
relatively common, however class II da) expression has 
seldom been reported. Class II expression in normal cells
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is now thought to be more widespread that has been 
generally realised (Natali et al, 1985). Consistent with 
the results of this study is the finding that class II 
molecules are relatively frequently seen in human malignant 
melanomas although not in epidermal melanocytes (Wilson et 
al, 1979, Natali et al, 1985, Burchiel et al, 1982). In 
human cultured cell lines HLA-DR expression in neoplastic 
melanocytes correlates with the ability to stimulate 
autologous lymphocytes in vitro (Guerry et al, 1984). 
However, the relevance of such studies to in vivo tumour 
behaviour must be questioned. Immunocytochemical studies 
have also shown HLA-DR to be present on poorly 
differentiated colon carcinomas (Rogum et al, 1983) and in 
a minority of gynaecological tumours (Ferguson et al,
1985). In the latter study there was no obvious 
relationship between HLA-DR expression and lymphocyte 
infiltration. It has been postulated that non-lymphoid 
cells which aberrantly express class II molecules are also 
able to present surface proteins to T cells and thus evoke 
an immune réponse (Botazzo et al, 1983). This hypothesis 
does not satisfactorily explain why cells which normally 
express class II MHC do not behave in this way.
Furthermore, attempts to test this hypothesis have not 
satisfactorily excluded the possibility that HLA-DR 
expression may be related to cell regeneration following 
injury. In the case of B16 FIO cells, which in vitro 
expressed relatively high levels of class II MHC, there was 
no histological evidence of a significant immune response 
to solid tumour deposits, although it did not prove 
possible to demonstrate expression in vivo by
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immunocytochemistry. Therefore, at the present time the 
functional significance of class II MHC in B16 melanoma and
other tumours remains unclear.
Immunocytochemical studies of human tumours have not 
revealed a consistent alteration in the expression of class 
I molecules in malignancy or in the degree of inflammatory 
response to the tumour. However, unlike class II molecule^, 
a number of experimental mouse tumours have been studied 
which provide a basis for discussion of the results of this 
experiment. Taken as a whole, aggressive and metastatic 
mouse tumour cell lines tend to have higher levels of class 
I MHC expression. This is consistent with the data 
presented here which show that the highly metastatic and 
lung homing FIO cell line had significantly increased 
expression of H-2 K and D than the similar, but poorly 
metastatic, Fl cell line. The detailed study of a number 
of other cell lines has led to the description of several 
mechanisms by which changes in H-2 expression could lead to 
alterations in tumour behaviour. One system which gives 
different results from the B16 melanoma are the tumours 
produced by adenovirus infection. When rat cells are 
infected with either Adl2 or Ad5 which are similar viruses 
only the former is able to produce tumours when injected 
into animals (Schrier et al, 1983). This is correlated with 
absence of class I MHC molecules from the cell surface.
The same experiment can be performed with murine cells and 
it can be shown that Adl2 infected cells are tumorogenic 
even across allogenic boundaries. However, the oncogenic 
property of Adl2 infected cells is abrogated when the H-2 L 
gene {Class I) is transfected with a promoter and enhancer
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(Tanaka et al, 1985), The explanation for this phenomenon 
is that cytotoxic T cells do not recognise the Adl2 antigen 
on the cell surface in the absence of H-2 class I molecules 
and so the cells are protected from immune destruction 
(Bernards et al, 1983).
A tumour cell line in which the more aggressive 
variant has higher H-2 expression is the Eb/ESb T cell 
lymphoma. This cell line originated from a chemically 
induced tumour (Schirrmacher et al, 1984). The highly 
metastatic ESb line expressed both H-2 K and D at a higher 
level than the less aggressive Eb line (Schirrmacher et al,
1984). There is some evidence that the ESb line has a 
higher degree glycosylation of H-2 than Eb. As a 
methylcholanthrene induced tumour Eb/ESb expresses tumour 
associated transplantation antigens which are different for 
the two cell lines, but both evoke a T cell response. Thus 
clearly the ESb cells have other mechanisms of immune 
escape than failure to express class I MHC. Although B16 
melanoma cells are not known to express tumour associated 
transplantation antigens, in the correlation of metastasis 
with H-2 class I expression they appear to resemble the
Eb/ESb system.
A further pattern of H-2 expression is seen in a
number of cell lines which show an altered ratio of H 2 D 
to H-2 K, This phenomenon is seen in the Lewis lung 
carcinoma (3LL), a spontaneously arising tumour of C57 
BL6. When a metastatic and a non-metastatic cell lines 
were compared it was found that no H-2 K was present on the 
metastatic cell line, but that H-2 D was present in both 
(Eisenbach et al, 1983). This work was extended by
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producing multiple clones from this tumour and examining 
H-2 expression and metastatic potential. A relatively good 
correlation was found between the D:K ratio and the ability 
to form metastasis (Eisenbach et al, 1984).
This type of relationship has been found in a number 
of other mouse tumours. The TIG sarcoma metastatic 
variants show higher D than K expression (Wallich et al,
1985). Furthermore correction of this D:K imbalance by 
transfecting K genes into T-10 cells resulted in cells 
which were unable to metastasise (Wallich et al, 1985).
The proposed mechanism by which this imbalance effects cell 
behaviour is through the abolition of the immune response. 
The evidence cited to support this is twofold. First in 
the case of the TIO sarcoma cells expressing H-2 K cells 
were able to metastasise in mice which has been irradiated 
(Wallich et al, 1985). Some caution is necessary in 
interpreting this as evidence of an immunological 
mechanism. It has been shown that local irradiation 
without demonstrable effects on immunity can lead to much 
higher metastasis of tumour to that particular area (Milas 
& Peters, 1984) the mechanism perhaps being mediated 
through local vascular injury. The second line of evidence 
are the observations made in AKR leukaemia cell lines. The 
K36 line which is H-2K deficient and rapidly growing is 
resistant to T cell mediated cytotoxicity. Transfection of 
the K gene restores sensitivity to T cell lysis (Hui et al, 
1984). This suggests that K is much more effective than D 
in presenting viral associated antigens to cytotoxic T 
cells (especially in the case of Gross leukaemia virus 
associated to tumours). Low levels of H-2K and resistance
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bo bro lysis are a feature of many other AKR
leukaemias, but several lines exist which express K and are 
lysed in vitro, but grow aggressively in vivo (Schmidt & 
Festenstein, 1982) (Plata, 1982). The AKR cell lines are 
also very unusual in that some may show expression of a new 
H-2 haplotype. The mechanism of this is not understood 
(Festenstein & Schmidt, 1981).
The antibody which is used in this study to measure 
H-2 class I expression recognised both K and D proteins and 
therefore the measured fluorescence was the sum of 
expression of these two molecules. Antibodies which would 
recognise Kb and Db separately were not available. The B16 
melanoma differs from the TlO sarcoma, AKR leukaemia and Eb 
lymphoma in that it was a spontaneously arising tumour and 
no tumour associated transplantation antigens have been 
described, nor has immune rejection been found to explain 
the differences in behaviour between the FlO and Fl cell 
lines. This raises the possibility that the elevated class 
I antigens may potentiate metastasis independent of the 
immune system. In the absence of specific antisera it was 
decided to attempt to alter the expression of H-2D by 
treatment of B16 cells with retinoic acid and observing 
changes in in vivo behaviour. The specific effect of 
retinoic acid in inducing elevated expression of H-2D has 
already been described in 3LL cells (Eisenbach et al,
1983).
When a concentration of retinoic acid identical to 
that used in the 3LL cell line (10-6% retinoic acid) was 
added to the culture medium a significant increase in both 
class I and class II MHC proteins were observed in both the
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FlO and Fl cell lines. Increase in MHC class II has not 
previously been described as an effect of retinoic acid. 
Although significantly greater numbers of Fl and FIO cells 
express these proteins, the magnitude of increase was much 
greater in the case of the Fl cell line. When the effects 
of retinoic acid were examined In vivo and in vitro the 
results were quite different from those seen with the 3LL 
cell line. At 10~6m retinoic acid cell growth was greatly 
inhibited and the formation of tumours following 
intravenous or intraperitoneal injection was reduced almost 
to zero. Careful histological examination of tissue from 
these animals showed no evidence of microscopic deposits of 
tumour which may have been expected if the effect of 
retinoic acid was solely to inhibit the rate of growth. As 
a result of these studies a titration of retinoic acid 
against in vitro growth was performed. This showed that 
growth inhibition ceased to be significant at 10“9m 
retinoic acid. When the immunofluorescence studies were 
repeated at this concentration it was found that there was 
no significant increase in MHC class I in either cell 
line. However even at this concentration there was a 
marked decrease in the number of tumours formed following 
intravenous or intraperitoneal injection. This experiment 
shows that in the Bl6 melanoma system retinoic acid 
inhibits metastasis formation by a mechanism which is 
independent of its inhibition of growth in vitro and of its 
induction effect on MHC class I and class II expression.
It has been suggested that retinoic acid may effect tumour 
progression in metastasis behaviour in vivo by virtue of 
presumed immunostimulatory effects (Ecoles, 1983). This was
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clearly not the case here as retinoic acid was not injected 
into the animals. Thus it appears that retinoic acid is 
able to induce irreversible or at least long lived 
inhibition of tumorogenicity in these cells.
From these studies it is apparent that retinoic acid 
has multiple effects on this cell line which makes it 
impossible to disentangle the effects of increased 
expression of MHC class I and class II and in vivo tumour 
formation. However, one variable which is independent of 
growth potential and appear to correlate well with 
metastasis formation is trapping of cells in the lungs 
following intravenous injection. Uninduced FIO cells were 
trapped more avidly than Fl cells in keeping with their 
differing metastatic potentials (Chapter 2). When the 
trapping of retinoic acid induced cells was studied it was 
found that trapping of Fl cells was greatly increased at 
10“6m retinoic acid but that 10“ 9m retinoic acid had no 
significant effect. This correlates with the changes in 
MHC expression seen at these concentrations of retinoic 
acid. However, the opposite was observed with FIO cells 
which showed a small inhibition of cell trapping at 10 6m 
retinoic acid again returning to control levels at 10~9% 
retinoic acid. One possible explanation for these results 
could be that the large increase in MHC seen in the Fl 
cells following treatment with 10“6m retinoic acid was 
sufficient to overcome an opposing effect and so increase 
cell trapping. In the FlO cells only a small stimulation 
of MHC was produced and so net inhibition of trapping could 
have resulted. However, in view of the complexity of the 
effects of retinoic acid in this system a number of other
explanations are equally possible.
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An alternative method of studying the involvement of 
histocorapatability molecules in the process of tumour 
metastasis is to attempt to show whether metastatic growth 
is restricted when animals of different genotypes are used. 
This is analogous to methods used to study in vitro cell 
interactions (Zinkernagel and Doherty, 1979). The initial 
approach to this question was to study the number of 
tumours produced when B16 FlO cells were injected into a 
semi-allogeneic animal. The animal chosen was a hybrid of 
C57 BL6 and balb c. (Appendix 4). This animal is 
heterozygous at all known polymorphic histocompatability 
loci but would accept tumours without immunological 
rejection (the tumours in this case being equivalent to a
graft from one of the parental animals). It was found
that the number of tumours produced in the lungs of these 
animals following IV injection was very much less than in 
the syngeneic recipients. In the hybrid animals there was 
no evidence of tumour deposits outwith the lungs and in 
this respect tumour cells behaved as they did in the 
syngeneic animal. These results would suggest that a 
strain related restriction effect was indeed present but
that it did not effect the preference of the tumour cells
for growth at a particular site.
To attempt to further define the locus involved in
this restriction effect hybrids were prepared by mating 
balb b with C57 BL6. The balb b strain is congeneic with
the C57 BL6 at the H-2 complex but in other respects is
identical to the balb c mouse. Thus, these hybrid animals 
were homozygous at the H-2 locus only. When B16 FIO cells 
were injected into these animals a large reduction in the
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number of metastasis was also observed similar to that seen 
with the C57 BL6 x balb c hybrid. This suggested that a 
restriction effect was present due to a locus other than 
H-2. It does not exclude the possibility that the H-2 
locus was also involved, merely that it was not solely 
responsible for the restriction effect. In order to test 
whether an H-2 mediated restriction effect was also 
present, it would have been necessary to test hybrids which 
were heterogenous at H-2 but were homozygous at all other 
loci. C57 B16 derived strains congenic at H-2 are not 
available, and unfortunately the closely related C57 Bl 10 
congenic strain are known to differ at a number of loci. 
(Appendix 4 ) .
Although it is not likely that an immune response 
could account for the difference observed between the 
syngeneic and hybrid animals it was possible that natural 
killer cell activity may have been responsible. Strain 
differences in NK activity are known to occur (Hanna and 
Fidler, 1981). To exclude this possibility spleen cells 
from C57 BL6 and hybrid animals were tested against FIO 
targets but no activity was found. Variable degree of 
resistance of FlO cells to NK lysis has previously been 
reported (Hanna and Fidler, 1981, Erlich et al, 1984,
Talmadge et al, 1980).
To characterise the restriction effect further, cells 
were injected directly into peritoneal cavity of C57 BL6 x 
balb c hybrids. In contrast to the results of intravenous 
injection there was no difference between the hybrid 
animals and the syngeneic recipients. When Cr ra 
labelled cells were injected a similar degree of lung
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trapping was observed at 2 hours and 4 hours in both types
of animal. These results raise the question as to the 
stage of the metastatic process at which the restrCction 
effect is operative. After being trapped in the pulmonary 
capillaries the tumour cells must emigrate into the lung
parenchyma, attach and begin to grow. If the factors which 
allow growth in the the peritoneal cavity are the same as 
those in the lung, then the stage of emigration from 
vessels would seem to be the likely point at which the 
restriction effect is acting. In view of the discussion in 
chapters 2 and 4 of local tissue effects on tumour growth, 
this assumption may not be justified and it remains 
possible that a factor involved in lung growth specificity 
may be responsible for the restriction effect. The idea is 
difficult to test as there is no comparable method of 
testing the effects of lung tissue on growth, direct 
injection being impractical.
In view of these results it is pertinent to ask 
whether this phenomenon has been observed in other types of 
metastasising tumour. The TIO sarcoma is a heterozygous 
tumour (H-2d x H-2k). It has been shown that in syngeneic
i.e. hybrid animals metastasis will occur only if the 
tumour cells express both parental haplotypes (Katsav et 
al, 1981) (DeBaetselier et al 1980). Clones were isolated 
from this tumour which expressed only one haplotype and 
were able to grow subcutaneously but did not metastasise 
(Katsav et al, 1983). Occasionally these clones 
spontaneously express both haplotypes and become 
metastatic. These effects were separate from the K.D 
imbalance described above. The authors of these studies
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suggested that the results could be explained by an 
immunological mechanism. However, the only evidence for 
this was enhancement of metastasis by irradiation and,as 
has been discussed above,irradiation can potentiate 
metastasis without an effect on the immune system. 
Furthermore, it is difficult to reconcile the observed 
local growth of the non-metastatic clones with an immune 
mechanism. An alternative explanation is that the 
phenomenon seen in theTlO sarcoma is similar to the results 
described above in Bl 6 melanoma in so far as both tumour 
and recipient organs lacked concordance of one allele. In 
both cases local growth was not impaired.
The Lewis lung carcinoma has been described in detail 
above. However, it is worthwhile considering the growth of 
this tumour in various strains. Unfortunately most studies 
using this tumour have assayed metastatic growth either by 
lung weight or uptake of 125i-iododeoxyuridine rather than 
by direct counting of the number of metastasis. Thus, the 
end point of these studies is not identical to those 
described here. It was found that the 3LL tumour grew 
locally in syngeneic and allogeneic mice (Isakov et al,
1981) but that growth was best in syngeneic or 
semi-allogeneic recipients. Using congenic Bl0 strains 
differing at H-2 it was found that most of this effect was 
non-H-2 mediated. Spontaneous metastasis occurred in 
syngeneic and semi-allogeneic but not in allogeneic mice. 
Furthermore it was found that this appeared to be 
controlled by loci outwith the H-2 complex as well as by 
the H-2D locus. One criticism of these studies is that 
hybrid C57 BIO congenic strains were used although the
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tumour is syngeneic with C57 BL6. As described above, in 
studying non-H-2 effects this difference may be 
significant.
Further experiments were performed to investigate the 
role of the immune system in these phenomena (Isakov et al,
1982). If neonatally tolerised C3H mice (which are 
allogeneic with 3LL) were injected with 3LL cells 
metastasis were found in about half the animals as compared 
to all the syngeneic animals (Isakov et al, 1982). (It 
should be noted that these results refer to spontaneous 
metastasis from footpad injection which is of course 
different from the method used in this study). Earlier 
work with this model made use of hybrid animals (Isakov et 
al, 1981) but these immune response experiments did not. 
Therefore, it is difficult to be certain that the same 
mechanism is operative. Furthermore, where an immune 
response is suspected lung weight and^Tododeoxyuridine 
uptake may not be the optimum measure of metastasis as 
inflammatory cell infiltration would produce changes in 
both these variables. However the results obtained with 
3LL in hybrids are in some respects similar to those 
described in the Bl6 melanoma in this study. A striking 
point of similarity is that histocompatability antigens 
seem to be much less important to local growth than to 
metastasis.
Another model which should be considered is the Eb 
lymphoma; this again has been described above. Like the 
3LL carcinoma interpretation of this work is very complex.
In most of these experiments the end point is taken at time 
of death and it is stated that the animals were rarely
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examined at post mortem (Schirrmacher, 1979). This is a 
less than satisfactory measure of metastasis but a number 
of points are worthy of note. It is stated that injection 
of one ESb cell into the syngeneic recipient (DBA/2) will 
be fatal in three weeks. The time taken for half the 
animals to die was 12& days after subcutaneous injection of 
105 cells. When an Fl DBA/2 x BIO D2 was used the time 
taken for half the animals to die was 30 days. This hybrid 
is homozygous at H-2 but differs in the minor histo­
compatability loci (Schirrmacher, 1979). This tumour is 
chemically induced and expresses a tumour associated 
transplantation antigen. It was demonstrated that 
additional resistance to the tumour could be transferred by 
sensitised lymphocytes. The difference between syngeneic 
and hybrid animals was not further discussed in this 
study. The ESb tumour commonly metastasises to the liver 
(Schirrmacher et al, 1980) and vitro forms rosettes with 
hepatocytes. This interaction can be blocked anti-H-2 
sera. The results of this study again appear similar to 
those described here.
The experiments described in this chapter indicate 
that the products of both the H-2 locus and other strain 
related polymorphic loci may be involved in mediating the 
process of metastasis. These findings are consistent with 
the results of a number of other studies, although in some 
cases it is difficult to separate the effects of the immune 
response. Given the large number of H-2 congenic and 
recombinant mouse strains which are now available it should 
be possible to explore further the role of the MHC loci, 
although for the reasons given the Bl6 melanoma is probably
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not the best model. For example it would be of interest to 
examine the question of K:D imbalance by varying the 
genotype of the animal rather than the tumour cells. This 
could be achieved using H-2 recombinant
strains.Investigation of non-H-2 polymorphic loci is a much 
more difficult problem. These include but may not be 
entirely synonymous with the non-H-2 class I genes. The 
production of antisera to the gene products and useful 
mouse strains would be an enormous task, although if the 
products of these genes are important mediators of cell 
interactions it may prove to be rewarding.
CHAPTER FOUR
GENERAL DISCUSSION.
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CHAPTER 4
GENERAL DISCUSSION
It is readily apparent from the preceding chapters of 
this thesis that the problem of tumour cell growth at 
different anatomical sites remains far from clearly 
understood. There is considerable debate on the general 
applicability of the various model systems which have been 
used to study this problem. Despite the obvious limitations 
of animal and cell culture models they remain useful as a 
source of ideas which can perhaps be tested in other ways. 
The experimental work described in chapters 2 and 3 
approach the problem of tumour growth at distant sites from 
two distinct viewpoints. In chapter 2 the effect of 
particular environments on tumour cell behaviour was 
considered. In chapter 3 the role that one group of cell 
surface molecules may have in the mediation of these 
interactions was examined. From this work a number of 
ideas have emerged.
a) Cell trapping by the vasculature as a determinant of the 
site of tumour growth.
Previous studies have suggested that the difference in 
lung homing behaviour of the Bl6 Fl and FIO melanoma cells 
could be due to differences in the trapping of these cells 
in the pulmonary capillary bed (Fidler, 1975). A 
difference in the trapping of Fl and FlO cels in the lung 
was confirmed in chapter 2. However a number of pieces of 
evidence from the experimental studies in this thesis 
suggest that trapping by capillary endothelium cannot be 
the sole explanation for the differing behaviour of these 
cell lines. Firstly, there is an approximately threefold
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difference in the trapping of Fl and FIO cells, but the 
number of tumours which arise in the lung after injection 
of FIO is about twenty times greater than after an 
injection of an equal number of Fl cells. A poor
correlation of cell trapping with tumour formation was also 
seen in studies of B16 growth in transplanted lung and 
other tissues (Hart & Fidler, 1980). This discrepancy is 
further supported by two other observations. The cell line 
derived from the peritoneal passaged Fl cells (Fl P16) had 
a much greater lung colonising ability than its parent cell 
line, but without any difference in the level of trapping 
in the lung. Secondly, the FlO cells injected into C57 BL6 
X balb c hybrid animals produced far fewer tumours but 
again with no change in the level of trapping. These 
studies suggest that while initial trapping may be 
important it cannot be the only determinant of the site at 
which a tumour will grow. In these experiments it is 
difficult to disentangle the relative contribution of 
initial vascular trapping from other factors which 
determine tumour cell growth. One model which would be 
useful in studying vascular trapping is the malignant 
lymphomas. Lymphocytes are naturally circulating cells 
(for review see deSousa, 1981). It has been suggested that 
trapping of lymphocytes by the high endothelial venules in 
lymphoid organs is central to the functioning of this 
circulation (Schoefl, 1972) (Woodruff et al, 1977). Indeed 
it is interesting in view of the results of Chapter 3 that 
the process of cell trapping by these vessels is MHC 
restricted (Degos et al, 1979). Lymphoid tumours, as large 
monoclonal populations, offer the opportunity to study
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vascular trapping at particular sites. Some recent studies 
with human extranodal lymphomas indicate that this may be a 
useful approach. It has been found that lymphomas arising 
in thyroid, stomach and salivary gland remain localised for 
long periods before becoming , ( Anscombe &
Wright, 1985) (Compagno & Outel, 1980 Moore & Wright,
1984  ^Hyman & Wolfe, 1976). The demonstration of
circulating cells in these tumours suggest that the 
neoplastic cells recirculate to their site of origin. The 
practical application of these studies is seen in the 
efficacy of surgical treatment of these tumours (Fleming et 
al, 1982).
b ) The effect of tissue environment on tumour cell growth 
The discrepancy between cell trapping and actual 
tumours arising in the lung points to the effect of the 
tissue environment in determining tumour cell growth. This 
finding can be further illustrated by the results of two 
further experiments described in chapter 2. Firstly, when 
cells from the benign salivary gland tumour were injected 
into the peritoneal cavity no evidence of tumour growth was 
found. Thus is can be concluded that the environment of the 
peritoneal cavity was not suitable for growth of these 
cells even although the tumour grew rapidly at its primary 
site. When small fragments of tumour were transplanted to 
this site these sometimes attached and the tumour cell 
survived but with little evidence of growth. This again 
suggests that the peritoneum was a non—permissive 
environment for the growth of this tumour although the 
tumour cells in association with their own stromal tissue 
were able to survive. A tumour which displays this type
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of site restriction is obviously a potentially useful model 
for studying the mechanisms underlying this type of 
behaviour. It is unfortunate that the practical 
difficulties of the mouse salivary tumour model prevented 
this i.e. failure to culture the cells and lack of an 
inbred host.
Secondly, the repeated passage of FI cells through the 
peritoneal cavity lead to the derivation of a cell line 
with quite different characteristics from its parent line 
(increased lung lesions, decreased peritoneal growth and 
poor in vitro proliferation). The change produced in this 
cell line was clearly of a more permanent nature than would 
be expected if the inhibited growth in the peritoneum was 
due, for example, to absence of a growth factor. Although 
repeated passage of a cultured cell line is clearly a 
highly artificial situation which is probably not 
comparable to any natural event it is of interest to 
consider what relevance these results may have for the 
phenomenon of tumour dormancy. Some of the clinical and 
experimental aspects of this condition are described in 
Chapter 1. It is possible that a particular tissue could 
cause profound suppression of previously rapidly growing 
tumour. This could result paradoxically in the emergence 
of a cell population with different properties perhaps by a 
mechanism analogous to the clonal instability phenomena 
described in Bl6 melanoma and other tumours (Poste et al, 
1981). This is one explanation for the emergence and 
behaviour of the Bl6 FI P16 cells as previously discussed.
c ) Selective and inductive mechanisms
The original derivation of the Bl6 FlO cell line
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involved repeated passage of cells which had formed 
pulmonary métastasés following intravenous injection. In 
the experiments described in Chapter 2 cell lines of 
different properties to the FI and FlO parent cell lines 
were derived by serial intraperitoneal passage. This 
raises the question as to whether these cells arose by 
selection of preformed sub-populations or by an inductive 
effect with peritoneal cavity. An inductive mechanism is 
one in which OnC tissue acts on another to alter its 
differentiation. It has two important elements firstly a 
signal and secondly a tissue competent to respond to this 
stimulus (for review see Slack, 1983). Such mechanisms are 
known to occur in embryogenesis.
There is some evidence to suggest a selective 
mechanism may be responsible at least for some of these 
observations. The study cited previously (Nicolson and 
Custed, 1982) where cells injected in microspheres were 
allowed to grow in the lung clearly favour the selective 
hypothesis. Repeated passage of the FlO cells resulted in 
a population which has a greater mesenteric tumour-forming 
ability but retained its lung colonising properties after 
intravenous injection. However after intravenous injection 
no tumours occurred in the peritoneal cavity. In this 
experiment growth at the site did not confer homing 
properties unless the vasculature involved. As the 
interaction with vessels is a transient step this probably 
again favours a selective mechanism.
The behaviour of the F1 cells is less easily explained 
on a selective basis. It is not easy to conceive of 
selective pressures which could produce a stepwise decrease
in mesenteric tumour formation as well as severely impaired 
in vitro growth, the latter being a permanent change. An 
inductive mechanism would seem more likely to account for 
this type of behaviour. If this were true then competence 
to respond to the inducing signal would be an important 
difference between the FlO and Fl cell lines. This may 
also explain some of the discrepancy between trapping and 
tumour formation as described above if such an inductive 
mechanism also operated in the lung.
The long lasting changes in the Fl cell line following 
intraperitoneal passage may reflect genomic changes, for 
examples, méthylation or even gene rearrangement. This 
could perhaps be studied using restriction enzyme 
polymorphisms although it would be a very laborious 
process. Such studies could however, provide an 
interesting insight into the mechanisms of actions of 
inducers with implications beyond the study of tumour 
biology.
Although these experiments are useful in so far as 
they raise the question of selection versus induction,it 
must be concluded that they do not go far toward separating 
the two effects.
d ) The molecular basis of tumour cell growth at distant 
sites
Investigation of the molecular basis of tumour 
metastasis has proved to be difficult probably because the 
concentrations of the important proteins and messenger RNAs 
are below the detection level of currently available 
techniques. The approach adopted in Chapter 3 was to look 
for strain-related restriction effects similar to those
seen in the immune system. Evidence cited in the 
introduction to Chapter 3 suggested that such restrictions 
were not exclusively confined to the immune system but may 
be a property of interactions between many other types of 
cells. A strain-related restriction of FlO lung metastasis 
formation was indeed found but this was not due to MHC 
differences. Further careful review of other published 
studies suggested a similar effect has been observed but 
interestingly largely ignored in other tumour cell models. 
Without precise molecular identification it is impossible
be
to^certain of the basis of this restriction effect.However 
one or more of the non-H-2 class I histocompatibility 
molecules would seem to be by far the most likely 
candidate. As yet class I and class II histocompatibility 
molecules are the only known mediators of restriction 
effects.
The possible involvement of a non-H-2 histocompat­
ibility model is of particular interest in view of the 
great diversity of these molecules, at least 50 genes being 
known in the mouse. The possible role of histocompat­
ibility molecules in relation to normal development has 
been discussed by Ohno (1977). Nothing is known about the 
control of these genes but it is obvious that a vast number 
of different combinations of their expression are possible 
and that this could be the basis of a complex system of 
cell interactions. The elucidation of this hypothesis 
depends on the availability of appropriate reagents and 
animal strains of a suitable genotype.
This thesis began by describing the clinical problems 
which had inspired the experimental study of metastasis. It
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is clearly of dubious validity to extrapolate the results 
of animal experiments to human patients, however a number 
of the ideas discussed above may lend themselves to further 
investigation in man.
Recent improvements in immunocytochemistry and in situ 
hybridisation readily lend themselves to the study of
histocompatibility antigen expression in metastasis and
surrounding host tissues. These studies may be more 
meaningful if these are viewed in the context of cell 
interactions between tumour and host tissue, rather than 
the narrow considerations of host immunity which has 
dominated previous studies of this type.
The effect of various tissues on the growth of
metastatic tumour cells could be investigated in a number 
of ways. Modern imaging technique could be used to monitor 
the growth rate of deposits at a variety of sites in the 
same patient. This would be of particular interest before 
and after excision of the primary tumour. Local recurrence 
after a long latent period is often seen, particularly in 
breast cancer. The application of the many available 
genetic and cell markers would show whether genetic or 
phenotypic changes had occurred. Finally, the study of 
human tissue growth factors is rapidly expanding. It is 
reasonable to expect that advances in this field will 
clarify many of the problems and provide mechanisms for the 
phenomena described above.
FIGURE 1
Specimen of stomach and duodenum showing extensive 
colonisation of the duodenal mucosa by metastatic malignant 
melanoma, but no evidence of spread to the adjacent gastric 
mucosa.
(Photograph courtesy of Prof. R.B. Goudie)
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FIGURE 2
Typical growth curve for B16 FlO melanoma cells. The 
number of cells per 80cm2 flask were counted and expressed
as mean 1 standard error.
A similar growth curve was observed with B16 Fl cells
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FIGURE 3
Relationship between the number of tumours counted on 
the pleural surface of both lungs to the area occupied by 
tumour deposits, as determined by histomorphometry.
Best fitting line determined by linear regression 
analysis.
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FIGURE 4
The number of lung tumours (counted as visible pleural 
deposits) which resulted from the intravenous injection of 
2 X 105 3X6 Fl0 cells was significantly greater than the 
number of tumours which followed from the injection of the 
same number of B16 Fl cell ( p ^ 0.0001).
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FIGURE 5
Comparison of the number of tumours in the small 
intestinal mesentry and serosa following injection of B16 
FlO and Fl cells. There is no significant difference in 
the number of tumours produced by each cell line.
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FIGURE 6
Comparison of number of lung tumours 1 SE) produced 
by intravenous injection of B16 FlO and FlO cells which had 
been passaged in the peritoneal cavity eighteen times (FlO 
P18). The difference in the mean number of tumours is not 
statistically significant.
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FIGURE 7
Comparison of the number of mesenteric deposits 
produced by intraperitoneal injection of B16 Fl (red) cells 
and Fl passaged 9 times (blue) and 16 times (green) through 
the peritoneal cavity.
Both passaged cell lines formed significantly fewer 
tumours than the unpassaged cell line (p< 0.01).
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FIGURE 8
Cultures of Bl6 FlO cells were labelled with Na^lcr. 
The medium was then replaced with non-radioactive medium 
and the retained radioactivity measured at various times.
From an experimental regression curve the half life of 
retention was estimated at 12.5 hours.
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FIGURE 9
Comparison of mean (=*= 1 SE) radioactivity in the lungs 
of animals injected with 51cr labelled FlO and Fl cells.
The measurements were made two hours after injection.
Significantly more FlO cells were trapped in the lungs 
than Fl cells (p( 0.0001).
The results are corrected to account for the 
efficiency of cell labelling as described in the text.
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FIGURE 10
Comparison of retention of r a d i o a c t i l a b e l l e d  B16 
FlO and Fl cells four hours after injection. There is 
significantly higher mean radioactivity in the lungs of 
animals injected with FlO cells (p^O.05).
Values quoted in Cpmg"! are corrected for efficiency 
of cell labelling.
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FIGURE 11
Adhesion of B16 FIO cells (darkly staining) to cryostat 
section of mouse liver. H - E X 395.
Æ
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FIGURE 12
B 16 FIO cells grown on a coverslip. Most cells are 
spindle shaped and mononuclear. H & E x 155.
FIGURE 1
B16 FI cells after seven passages in the peritoneal 
cavity. Increased number of multinucleated cells were 
present. H & E X 990.
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FIGURE 14
Fl cells incubated with 3,4 dihydroxy phenylalamine to 
demonstrate melanin synthesis. Reaction product is visible 
as dense cytoplasmic granules.
FIO and passaged cell lines also reacted positively 
with this reagent.
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FIGURE 15
Section of lung from a mouse injected with B16 FIO
cells. A metastatic deposit of melanoma is present
surround ing a thin walled blood vessel. This was a
commonly observed feature in lung deposits of this
tumours. H & E X 395.
FIGURE 16
Section of lung showing deposit of Bl6 Fl0 cells 
growing under the pleural surface. H & E x 314.
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FIGURE 17
Deposits of Bl6 Fl melanoma growing on the serosa and 
mesentry of the small intestine following intraperitoneal 
injection.
FIGURE 18
Section of small intestine with adjacent deposit of 
Bl6 FIO melanoma growing in the serosal fat. H & E x 125
mi
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FIGURE 19
Mouse polyoma virus induced salivary gland tumour. 
This section shows a nodule of tumour separated from the 
adjacent normal gland by a thin fibrous capsule. There is 
no evidence of invasion.
A scattered lymphoid infiltrate is visible within the 
tumour. H & E X 190.
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FIGURE 20
Section of peritoneum with attached deposit of mouse 
polyoma salivary tumour. The tumour was transplanted as a 
small cube of tissue four weeks previously. The tumour is 
attached by reactive fibrous tissue at its edge but shows 
little significant increase in size. H & E x 20.

FIGURES 21 & 22
FACSII plots of number of cells (y-axis) and intensity 
of staining (x-axis). The intensity of fluorescence is 
measured in 25 6 steps.
Figure 21 shows a plot obtained/from FIO cells stained 
with anti H-2b(Kp) Figure 22 shows a plot for Fl0 cells 
stained by the same method but omitting the specific 
antiserum. It is therefore a measure of cell 
autofluorescence and non-specific binding on rabbit 
anti-mouse immunoglobulin FITC conjugate.
NB: The y-axis scale on these diagrams is randomly
selected by the microcomputer and is not comparable for 
Fig. 21 and 22. The same number of cells counted in
each case.
F:-%Ü/ 8/E
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FIGURES 23, 24, 25
Plots of cell size (y-axis) versus fluorescence 
intensity.
Fig. 23: shows the size/intensity relationship for Bl6 
FIO cells stained with anti-H-2(KD). There is no apparent 
correlation between size and intensity.
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FIGURE 24
Fig. 2 4 shows the size/intensity relationship for Bl6 
Fl cells stained with anti-l-A. The vertical band 
represents unstained cells. The near horizontal band are 
cells stained with the antibody. Again there is no 
relationship between size and intensity.
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FIGURE 25
Fig. 25 : shows a similar plot for cells stained by the 
same procedure omitting the primary antisera.
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FIGURE 26
Graph showing the effect on cell growth of of Bl6 FIO 
cells with varying concentrations of retinoic acid. At 
concentrations of 10-6 - 10-8% retinoic acid there was 
significant impairment of growth as compared to untreated 
control cells.
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FIGURE 27 - 32
These histograms show the effect of retinoic acid on 
the number of cells stained with an antibody at twelve 
levels of intensity. The results are expressed as 
cumulative percentages. Channel 256 counts the most 
fluorescent cells and channel 1 the least. For example the 
band 121-256 represents all the cells counted in channels 
121-256. This is referred to as high intensity in the 
text.
In calculating the percentage of cells stained, the 
number of autofluorescent cells was subtracted using the 
formula described in the text, (materials and method 
section of Chapter 3). There was no further increase in 
the number of cells in band 1-20, therefore for the sake of 
clarity this is not shown.
(MCA 45 = MRC OX-3
(MCA 64 = 5041-16.3
Fig. 27: The effect of 10”6m retinoic acid on H-2(KD)
expression in FI cells. The difference is statistically 
s igni ficant.
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FIGURE 28
This graph shows the effect of 10-6 retinoic acid on 
I-A expression in FI cells. The increase is statistically 
significant.
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FIGURE 29
This graph shows the effect of 10-6% retinoic acid on 
H-2(KD) expression in FlO cells. The increase is 
statistically significant.
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FIGURE 30
This graph shows the effect of 10"6% retinoic acid I-A 
expression in FlO cells. This increase is statistically 
significant.
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FIGURE 31
This graph shows the effects of 10~9m retinoic acid on 
T-A expression in Fl cells. The difference is not 
significant.
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FIGURE 32
This graph shows the effect of 10-9# retinoic acid on 
FlO cells stained for H-2KD. The difference is not 
s ignificant.
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FIGURE 33
The effect of retinoic acid on tumour forming ability 
of B16 FlO cells following IV injection. No tumours were 
seen with cells treated with 10“^M retinoic acid. A 
significant decrease was seen with cells treated with 10“  ^
retinoic acid (p< 0.0001).
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FIGURE 34
The effect of retinoic acid on lung tumour formation 
by Fl cells. No tumours were seen with cells treated with 
10“6m retinoic acid. A decrease was seen with lO-^M 
retinoic acid but was not significant.
Note: Change in y-axis scale from Fig. 33.
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FIGURE 35
The effect of retinoic acid on the formation of 
mesenteric tumours by FlO cells following IP injection. 
Cells induced with 10-6% retinoic acid formed no tumour. A 
significant decrease was found at 10“^M retinoic acid.
125-
NUMBER OF TUMOURS
(MEAN +1SE)
100 -
75-
5 0 —
25-
C E L L  T Y P E
B 1 6  F l O B 1 6  F l O
Induced with 
10'® M Retinoic
B 1 6  F l O
Induced with 
10"® M Retinoic
157
FIGURE 36
The effect of retinoic acid on the formation of 
mesenteric tumours by Fl cells injected IP. No tumours 
were found with cells induced by 10-6% retinoic acid. A 
significant decrease was seen at 10”^M retinoic acid.
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FIGURE 37
The effect of retinoic acid on the trapping of 
radiolabelled FlO cells in the lung. A significant 
decrease is seen when cells were induced with 10-6% 
retinoic acid. Cells induced with 10”^M retinoic acid 
showed no significant difference.
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FIGURE 38
The effect of retinoic acid on trapping of Fl cells in 
the lung. A significant increase in cell trapping is seen 
when cells were induced with 10-6% retinoic acid. No 
difference is seen when 10~^M retinoic acid was used.
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FIGURE 39
Injection of FlO cells into hybrid animals which were 
with heterozygous (b x k) or homozygous (b x b) at H-2 
resulted in a significant decrease in the number of lung 
tumours as compared to the syngeneic strain (C57 B16).
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FIGURE 40
Comparison of the ability of FIO cells to form 
mesenteric deposits in the syngeneic strain (C57 B16) and 
hybrid strain (C57 Bl6 x balb c). This difference is not 
significant.
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FIGURE 41
Comparison of lung trapping of radiolabelled FIO cells 
in syngeneic (C57 B16) and hybrid (C57 B16 x balb c) 
animals measured at 2 hours. There is no significant 
difference.
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FIGURE 42
Comparison of lung trapping of FIO cells in syngeneic 
and hybrid animals at 4 hours. The difference is not 
significant. Note the decrease in total radioactivity as 
compared with Fig. 41.
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APPENDIX 1 
Solutions used in Tissue Culture
Medium A
1. Nutrient Mixture Ham FIO (Tenfold concentrate) 20ml
2. 7.5% solution of NaHCO] 1ml
3. GPSA solution 5ml
(200mM c-Glutamine)
(5000 iu/ml Penicillin)
(5000 iu/ml Streptomycin)
( 250 wg/ml Amphotericin B)
4. 2.95% Tryptose Phosphate in water 20ml
5. Foetal Calf Serum 20ml
6. 20mM Hepes in water. 180ml
Medium B
1. Medium A without Foetal Calf Serum 
13mls
2. Foetal Calf Serum
3. Glycerol
6m 1 
1ml
1. Na Cl
2. K Cl
3. Glucose
4. Hepes
Hepes Buffered Sali ne
8g )
0.4g ) made up to 1 litre in deionised 
Ig ) water.
2.4g )
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APPENDIX 2
Radiolabelling of Bl6 cells and 
measurement of cell trapping
A. Labelling B16 cells in medium A,
I
Replace with medium A containing 
3MBq/100ml' of Na^lCr
Incubate overnight
I
Wash X 2 in MEM and resuspend to 
106 cells ml"l
4
radioactivity in 0.1ml aliquot of cells measured.
B. Trapping 2 x 105 labelled cells injected IV.
2 or 4 hours later - lungs removed and 
weighed.
Radioactivity counted - expressed as 
cpm/g (wet weight)
C. Calculaton
cpm/g X 100 0 
cpm in 0.1ml = cpm/g corrected
of cell suspension for efficiency of
cell labelling.
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APPENDIX 3
The mouse H-2 major histocompatability complex
In the H-2 notation the superscript lower case letter 
eg H-2b denotes the haplotype. The haplotype is a unique 
combination of shared and unique antigenic determinants.
Each MHC class I gene product (K,D and L) has both 
individual and shared class I specificities.
e.g. gene product Antigenic Determinants.
H-2Kd 3, 8, 22, 28, 29, 34, 46, 47, 31*.
H-2Dd 3, 6, 13, 27, 28, 29, 35, 36, 41,
42, 43, 44, 49, 4*.
* unique determinants.
Chromosome 17
H-2 Tia
30 class I  genes and 
pseudogenes
G e n e  K 
Glass I
A/3
n
A  a 
E
E/3
E E
S
m
D
I
L
I
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APPENDIX 4
Mouse Histocompatability Genotypes
GENE H—1 H-2 H-3 H-4 H-5 H-6 H-7 H-8 H-9 H-12 H-13 H—14
CHROMOSOME 7 17 2 7 * 2 * •k * * 2 k
STRAIN
C57 B16 c b a a
not 
a or b a a a
not 
a or b a a b
Balb c b d c * * b c b a d ■k
Balb b b b c * ■k * b c b a d k
C57 BLIO c b a a * a & b a a a a a b
* not known
not a or b - not precisely typed, 
a & b - reacts with sera to a and b.
Data supplied by Olac Ltd, Blackthorn, Oxfordshire
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APPENDIX 5
Method for Natural Killer Cell Assay.
A . Target cell Preparation
Cultures of B16 FIO cells
18 hours in Medium A with 3MBq/100ml of 
NaSlcr
I
Wash in Medium A.
i
5 X 104 cells in SOyil of medium per well
B. Effector Cells Preparation
Spleen from C57 B16 or C57 Bl6 x Balb c.
i
Cut and compressed to remove lymphoid cells.
I
Washed in medium A.
4
1 hour at 37°C to remove adherent cells.
4
Resuspend and add to microtitre wells in varying 
proportions.
169
C . Control
1) Target cells incubated with medium (S). 
ii) Target cells incubated with Nonindet P-20 (M).
D. Results
T - S X 100 
NK cytotoxicity = M - S
Where T is radioactivity in wells with effector cells 
added.
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